# EDGAR Filing Document

**Accession Number:** 0001833756
**File Stem:** 0001628280-23-009265
**Filing Date:** 2023-3
**Character Count:** 248136
**Document Hash:** 598d5479d0ab641bbad8362afdb82ba6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-23-009265.hdr.sgml**: 20230327

**ACCESSION NUMBER**: 0001628280-23-009265

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 115

**CONFORMED PERIOD OF REPORT**: 20230327

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230327

**DATE AS OF CHANGE**: 20230327

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Leonardo DRS, Inc.
- **CENTRAL INDEX KEY:** 0001833756
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEARCH, DETECTION, NAVIGATION, GUIDANCE, AERONAUTICAL SYS [3812]
- **IRS NUMBER:** 132632319
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41565
- **FILM NUMBER:** 23764849

**BUSINESS ADDRESS:**
- **STREET 1:** 2345 CRYSTAL DRIVE
- **STREET 2:** SUITE 1000
- **CITY:** ARLINGTON
- **STATE:** VA
- **ZIP:** 22202
- **BUSINESS PHONE:** (703) 416-8000

**MAIL ADDRESS:**
- **STREET 1:** 2345 CRYSTAL DRIVE
- **STREET 2:** SUITE 1000
- **CITY:** ARLINGTON
- **STATE:** VA
- **ZIP:** 22202

?xml version="1.0" ? drs-20230327

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

____________________________________

**FORM 8-K** 

____________________________________

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): March 27, 2023**

____________________________________

**LEONARDO DRS, INC.** 

**(Exact name of registrant as specified in its charter)**

____________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-4165** | **13-2632319** |
| **(State of Incorporation)** | **(Commission<br>File Number)** | **(IRS Employer<br>Identification Number)** |

---

**2345 Crystal Drive**

**Suite 1000**

**Arlington, Virginia 22202**

**(Address of principal executive offices)**

**(703) 416-8000**

 **(Registrant's telephone number, including area code)**

____________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| Title of class | Trading Symbol | Name of each exchange on which registered |
| Common Stock, $0.01 par value | DRS | The Nasdaq Stock Market LLC |

---

------

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 8.01. Other Events.**

Leonardo DRS, Inc. (the "Company") is filing this exhibit to reflect changes to the presentation of our financial information as set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "2021 Form 10-K"), as filed with the Securities and Exchange Commission (the "SEC") on March 28, 2022, and updated on Form 8-K as filed with the SEC on August 2, 2022 (the "August 8-K"), in order to give effect to the Company's stock split, a 1.451345331-for-1 forward stock split on our common stock, as effected November 23, 2022 (the "Stock Split").

As previously disclosed in the 8-K12B filed with the SEC on November 28, 2022, the Company's Board of Directors (the "Board") and US Holding, LLC, at that time the sole stockholder of the Company, adopted resolutions approving the Stock Split with an effective date of November 23, 2022, when the Company filed an Amended and Restated Certificate of Incorporation (the "A&R Certificate of Incorporation") with the Secretary of State of the State of Delaware to amend and restate the Company's Certificate of Incorporation, as amended, restated or amended and restated from time to time, to effect the Stock Split and increase the authorized shares of Company Common Stock from 300,000,000 to 350,000,000. The Stock Split became effective as of the effective date of the A&R Certificate of Incorporation, November 23, 2022.

Upon effectiveness of the Stock Split, each outstanding share of the Company's Common Stock was, without any further action by the Company, or any holder thereof, converted into, and automatically became, 1.451345331 shares of the Company's Common Stock. No fractional shares were issued as a result of the Stock Split. In lieu thereof, fractional shares were rounded up to the nearest whole share.

Prior to the filing of the A&R Certificate of Incorporation, the Company had 300,000,000 shares of Company Common Stock authorized, out of which 145,000,000 shares were issued and outstanding. As a result of the filing of the A&R Certificate of Incorporation, and resulting effectiveness of the Stock Split, the 145,000,000 shares of the Company's Common Stock issued and outstanding immediately prior to the Stock Split were converted into approximately 210,445,073 shares of the Company's Common Stock. The Stock Split did not change the number of the Company's authorized shares of preferred stock, or their par value.

Exhibit 99.1 updates information in the following items as initially filed in order to reflect the Stock Split: Part II. Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations; and Part II. Item 8, Financial Statements and Supplementary Data. No items in the 2021 Form 10-K and the August 8-K other than those identified above are being updated by this filing. Information in the 2021 Form 10-K and August 8-K is generally stated as of December 31, 2021, and August 2, 2022, respectively, and this filing does not reflect any subsequent information or events other than the Stock Split noted above. Without limiting the foregoing, this filing does not purport to update Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the 2021 Form 10-K for any information, uncertainties, transactions, risks, events, or trends occurring, or known to management, other than the events described above. More current information is contained in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 and other filings with the SEC. This exhibit should be read in conjunction with the 2021 Form 10-K, the August 8-K, and the Form 10-Q for the quarter ended September 30, 2022, and any other documents we have filed with the SEC subsequent to November 7, 2022.

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits

---

| | |
|:---|:---|
| **Exhibits** | |
| 99.1 | <u>[Revised portions of the Leonardo DRS, Inc. Annual Report on Form 10-K for the fiscal year ended December 31, 2021](drs-20230327_d2.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **LEONARDO DRS, INC.** | **LEONARDO DRS, INC.** |
|  | **(Registrant)** | **(Registrant)** |
| Date: March 27, 2023 | By: | /s/ Mark A. Dorfman |
|  |  | Mark A. Dorfman |
|  |  | Executive Vice President, General Counsel and Secretary |

---

## Exhibit 99.1

?xml version="1.0" ? drs-20230327_d2

**Exhibit 99.1**

**EXPLANATORY NOTE**

Leonardo DRS. Inc. (the "Company," "we," "us," "our") is filing this exhibit to reflect changes to the presentation of our financial information as set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "2021 Form 10-K"), as filed with the Securities and Exchange Commission (the "SEC") on March 28, 2022, and updated on Form 8-K as filed with the SEC on August 2, 2022 in order to give effect to the Company's Stock Split (a 1.451345331-for-1 forward stock split on our common stock) as effected November 23, 2022.

As previously disclosed in the 8-K12B filed with the SEC on November 28 2022, the Company Board and US Holding, the sole stockholder of the Company, adopted resolutions approving the Stock Split with an Effective Time, on November 23, 2022, the Company filed an Amended and Restated Certificate of Incorporation (the "<u>A&R Certificate of Incorporation</u>") with the Secretary of State of the State of Delaware to amend and restate the Company's Certificate of Incorporation, as amended, restated or amended and restated from time to time, to effect the Stock Split and increase the authorized shares of Company Common Stock from 300,000,000 to 350,000,000. The Stock Split became effective as of the effective date of the A&R Certificate of Incorporation, November 23, 2022.

Upon effectiveness of the Stock Split, each outstanding share of the Company's Common Stock was, without any further action by the Company, or any holder thereof, converted into, and automatically became, 1.451345331 shares of the Company's Common Stock. No fractional shares were issued as a result of the Stock Split. In lieu thereof, fractional shares were rounded up to the nearest whole share.

Prior to the filing of the A&R Certificate of Incorporation, the Company had 300,000,000 shares of Company Common Stock authorized, out of which 145,000,000 shares were issued and outstanding. As a result of the filing of the A&R Certificate of Incorporation, and resulting effectiveness of the Stock Split, the 145,000,000 shares of the Company's Common Stock issued and outstanding immediately prior to the Stock Split were converted into approximately 210,445,073 shares of the Company's Common Stock. The Stock Split also did not change the number of the Company's authorized shares of preferred stock, or their par value.

This exhibit updates the information in the following items as initially filed in order to reflect the stock split: Part II. Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations; and Part II. Item 8, Financial Statements and Supplementary Data. No items in the 2021 Form 10-K and as updated on Form 8-K other than those identified above are being updated by this filing. Information in the 2021 Form 10-K and updated on Form 8-K is generally stated as of December 31, 2021 and August 2, 2022, respectively, and this filing does not reflect any subsequent information or events other than the stock split noted above. Without limiting the foregoing, this filing does not purport to update Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the 2021 Form 10-K for any information, uncertainties, transactions, risks, events, or trends occurring, or known to management, other than the events described above. More current information is contained in our Quarterly Report on Form 10-Q for the period ended September 30, 2022 and other filings with the SEC. This exhibit should be read in conjunction with the 2021 Form 10-K, the Form 8-K filed August 2, 2022, and the Form 10-Q for the period ended September 30, 2022, and any other documents we have filed with the SEC subsequent to November 7, 2022.

**PART II**

------

**ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

*You should read this discussion together with our consolidated financial statements and related notes thereto included elsewhere in this Annual Report.*

*This discussion and other parts of this document include forward-looking statements such as those relating to our plans, objectives, expectations and beliefs, which involve risks, uncertainties and assumptions. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in "Risk Factors" and "Special Note Regarding Forward-Looking Statements and Information." Actual results may differ materially from those contained in any forward-looking statements.*

 **Business Overview and Considerations**

***General***

DRS is a leading provider of defense products and technologies that provide battlefield superiority today while shaping the battlefield of tomorrow for the U.S. military and our allies abroad. We offer a broad portfolio of products and services in our core technologies including advanced sensing, electronic warfare ("EW") and cyber, network computing, communications, force protection, and electrical power conversion and propulsion. Our leadership positions in these markets have created a foundational base of programs within the DoD that has yielded five straight years of organic revenue growth. We believe these technologies will not only support our Armed Services in today's mission but will also underpin the DoD's strategy to migrate towards more autonomous, dynamic, interconnected, and multi-domain capabilities needed to win in tomorrow's battlefield. We expect that the DoD's focus on effectively countering growing peer threats from China and Russia while simultaneously pursuing a counter-terrorism strategy against asymmetrical organizations and actors will increase its reliance on the core technologies that DRS provides, reinforcing our position in our high growth markets.

Our overall strategy is to be a balanced and diversified company, less vulnerable to any one budgetary platform or service decision with a specific focus on establishing strong technical and market positions in areas of priority for the Department of Defense ("DoD"). The DoD is our largest customer and, for the years ended December 31, 2021 and 2020, accounted for approximately 86% and 84%, respectively, of our business as an end-user, with revenues principally derived directly or indirectly from contracts with the U.S. Army and U.S. Navy, which represented 38% and 31%, and 43% and 32%, respectively, of our total revenues for the years ended December 31, 2021 and 2020.

We use our technical capabilities, customer relationships and product quality to drive our financial performance, evidenced by a 10% CAGR in revenue from the year ended December 31, 2017 through the year ended December 31, 2021, which drove our annual revenue to $2.9 billion for the year ended December 31, 2021. During the same period, net earnings improved by $245 million to $154 million, our operating earnings grew $187 million to $236 million, and our Adjusted EBITDA grew $129 million to $310 million (CAGR of 14%). Adjusted EBITDA is a non-GAAP measure, see "—Key Financial and Operating Measures—Non-GAAP Financial Measures" below for a reconciliation of Adjusted EBITDA to net earnings.

Our operations and reporting are structured into the following two technology driven segments based on the capabilities and solutions offered to our customers:

*Advanced Sensing and Computing*

Our Advanced Sensing and Computing ("ASC") segment is organized to provide equipment that enables the capture and communication of value battlefield information necessary to ensure our armed forces are equipped with real-time intelligence required to deliver enhanced decision making and execution in theater. From leading long-range sensing capabilities, expanding our reach, to rugged,

------

**Exhibit 99.1**

trusted, and cyber resilient computing, our ASC products provide our customers with the ability to be successful in their mission.

Our ASC segment provides ground vehicle systems including third generation infrared, long-range threat detection, situational awareness, targeting and vehicle protection. Additionally, we offer a full complement of soldier systems, including next generation sensors, targeting systems and optics to improve infantry combat effectiveness. Our sensing technologies also support aircraft survivability through advanced two-color infrared sensors and our quantum cascade lasers which detect and protect aircraft from missile attacks.

In addition to our optical sensing systems, we utilize state of the art technology in EW and cyber systems to provide our customers integrated capabilities for multi-domain operations to supplement kinetic warfare. Our mounted and dismounted EW systems and intelligence solutions across a broad range of platforms bring world-class capability to our customers.

Our sensing capabilities are complemented by our network computing and communications products. We are the leading global supplier of battle management systems and mounted computing hardware for ground forces worldwide. For the U.S. and allied naval customers, we provide naval computing systems and networks, shipboard communications, radar, surface ship and submarine combat and command and control systems.

*Integrated Mission Systems* 

&nbsp;&nbsp;&nbsp;&nbsp;Our Integrated Mission Systems ("IMS") segment provides critical force protection, vehicle integration, transportation and logistics and electrical control, distribution and conversion, and ship propulsion systems to the U.S. military and allied forces. As the U.S. military continues to defend our national security interests across the globe, our technologies and systems help protect U.S. forces and assets against increasingly sophisticated and proliferating threats. Our force protection systems, including solutions for counter-unmanned aerial systems, short-range air defense systems and active protection systems used to defend ground combat vehicles help protect service members and military assets from these growing threats, highlighted by the recent deployment of the Mission Equipment Package ("MEP") for the Maneuver Short-Range Air Defense ("M-SHORAD") program by the U.S. Army.

We also provide power control, distribution, conversion and propulsion systems for the U.S. Navy's top priority shipbuilding programs, including the Columbia Class ballistic missile submarine, the first modern U.S. electric drive submarine as well as other advanced equipment to the U.S. Navy, U.S. Coast Guard, and international navies including hybrid electric drive propulsion systems, energy storage, gas turbine packages, nuclear instrumentation and controls, and thermal management and refrigeration equipment.

Current and future platforms require more power than before as a result of the advancement of directed energy weapons, increased on-board computing, and increased sensing. As a result, these platforms must be able to adapt their propulsion to the situation around them, increase their stealth in a threatened environment, or speed to the objective if unthreatened. Our IMS segment provides technologies that fulfill these needs for power and have developed propulsion for various platform types. For example, as the U.S. Navy fleet grows, we expect that it will require new forms of integrated power systems. Our electrical drive technology provides the ability to direct energy to these evolving needs and adapt propulsion based on an evolving threat situation. These capabilities can also be used on unmanned platforms. As a leading provider of next-generation electrical propulsion components and systems for the U.S. Navy, we believe DRS has the technology to provide electrical power capabilities to service the future fleet's needs.

***Focus on Customer and Execution***

DRS and its employees focus on our end-customers – the men and women of the armed forces in the U.S. and its allies. We seek to provide high-quality equipment and services to support their mission success. We strive for excellence in everything we do, in every job in our Company, in order to satisfy our

------

**Exhibit 99.1**

customers' needs embedded in our contractual commitments. We seek to ensure that we learn from every lesson experienced in our Company and insist that these lessons affect all elements of our businesses. This approach permeates through the Company with a focus on continuous improvement at every level.

Part of this learning has resulted in institutionalizing our continuous improvement process through our APEX program. The APEX program's goal is to strive for continuous improvement through unification of our business practices, tools and metrics, ongoing employee training and innovation. We believe that excellence is not a destination, but by constantly challenging ourselves to be better, we will improve, and ultimately approach excellence. We challenge ourselves to exceed our customers' expectations and we partner with them to work to ensure that our execution meets their needs.

Continuous improvement, through the APEX program also allows us to improve our efficiency, which contributes to increased margins, helps us to remain competitive and allows us to make strategic investments, all while maintaining our focus on customer satisfaction. In these elements, our goals are aligned with those of our customers. We are humbled by the dedication and sacrifice that our ultimate customers have made to serve and we work to perform for them with excellence in everything we do.

***Impacts of COVID-19 On Our Business***

The coronavirus (COVID-19) pandemic has caused significant disruptions to national and global economies and government activities since March 2020. We continue to closely monitor COVID-related impacts on all aspects of our business and geographies, including on our workforce, supply chain and customers.

The United States has taken several steps to respond to the pandemic. On September 9, 2021, President Biden announced a COVID-19 action plan, including an executive order, the Safer Workforce Task Force guidance issued on September 24, 2021 and the DoD's Force Health Protection guidance. This executive order and guidance (as amended) contained a clause that required covered federal contractors and subcontractors to implement federally required vaccine mandates. This clause was implemented into several of our applicable federal contracts. In light of certain of certain court orders, however, the office of Management and Budget has stated that the U.S Government will not take action to enforce this clause until further notice. If ultimately upheld, this federal contract requirement may impact several of our contracts. We are continuing to evaluate these evolving requirements, especially as our customers determine when and how to implement the potential contractual requirements. We cannot at this stage predict the various impacts they may have on our workforce, our suppliers, or our company. These evolving government requirements, along with broader impacts of the continuing pandemic, could impact our workforce and performance, as well as those of our suppliers.

The proactive management to mitigate the impact of COVID-19 has enabled our business to remain operational. However, we incurred an additional $7 million of expenditures from January 1, 2021 thru December 31, 2021, related to ensuring a safe work environment for our employees. This is in addition to $12 million of expenditures incurred from March 1, 2020 through December 31, 2020. These costs included paid leave, personal protective equipment and other cleaning measures, facility filtration systems and social and physical distancing efforts, including the use of zones and subzones for manufacturing facilities to implement quarantining protocols. Costs to combat the COVID-19 pandemic have been excluded from our Adjusted EBITDA results. See "—Key Financial and Operating Measures—Non-GAAP Financial Measures."

We continue to review our mitigation efforts to respond to the changing COVID-19 environment, and are engaged in planning and adapting to a future workforce for when there is a return to normalcy.

***Business Environment***

Revenues derived directly, as a prime contractor, or indirectly, as a subcontractor, from contracts with the U.S. government represented 86%, 84% and 89% of our total revenues for the years ended

------

**Exhibit 99.1**

December 31, 2021, 2020 and 2019, respectively. Our U.S. government sales are highly concentrated within our DoD customers, which made up the overwhelming majority of our U.S. government revenue for the year ended December 31, 2021 and are principally derived directly or indirectly from contracts with the U.S. Army and U.S. Navy, which represented 38% and 31%, respectively, of our total revenues for the year ended December 31, 2021. Therefore, our revenue is highly correlated to changes in U.S. government spending levels, especially within the DoD.

President Biden's administration has identified the key threats America faces, which emanate from great powers and regional adversaries, and also from non-state actors and extremists, as further described in Part I, Item I, "Business" in this Annual Report. We believe the DoD priorities, the FY2022 budget request, authorization and appropriations bills align with DRS' product offerings and our ability to innovate our core technology and investment focus.

In addition to the U.S. market, DRS has important positions internationally in the Middle East, U.K., Australia, Korea and Taiwan in areas such as Tactical Battlefield Management Systems, Thermal Weapons Sites, Combat Aircraft Training and Power and Propulsion programs, among others.

**Year Ended December 31, 2021**

**Key Financial and Operating Measures**

***Overview***

We measure our business using both key financial and operating data including key performance indicators ("KPIs") and non-GAAP financial measures and use the following metrics to manage our business, monitor results of operations and ensure proper allocation of capital: (i) Revenue, (ii) Bookings, (iii) Backlog, (iv) Adjusted EBITDA, (v) Adjusted EBITDA Margin, (vi) Adjusted Earnings Per Share ("EPS"), (vii) Leverage Ratio, and (viii) Free Cash Flow. We believe that these financial performance metrics represent the primary drivers of value enhancement, balancing both short and long-term indicators of increased shareholder value. These are the metrics we use to measure our results and evaluate our business and related contract performance. See "—Results from Operations" for further detail.

***Financial and Operating Data***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended Year Ended December 31,** | **Year Ended Year Ended December 31,** | **Year Ended Year Ended December 31,** | **Year Ended Year Ended December 31,** |
| (Dollars in millions, except per share amounts) | **2021** | **2021** | **2020** | **2019** |
| Total revenues | $2879 |  | $2778 | $2714 |
| Bookings | 2595 |  | 3055 | 2923 |
| Backlog | 2861 |  | 3291 | 2844 |
| Adjusted EBITDA<sup>(1)</sup> | 310 |  | 268 | 234 |
| Adjusted EBITDA Margin<sup>(1)</sup> | 10.8 | % | 9.6% | 8.6% |
| Adjusted EPS<sup>(1)(2)</sup> | $0.78 |  | $0.50 | $0.36 |
| Leverage Ratio<sup>(1)</sup> | 0.5 | x | 0.9x | 2.3x |
| Free Cash Flow<sup>(1)</sup> | $118 |  | $74 | $110 |

---

________________

------

**Exhibit 99.1**

(1)Note on non-GAAP financial measures: Throughout the discussion of our results of operations we use non-GAAP financial measures including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EPS, Leverage Ratio and Free Cash Flow, as measures of our overall performance. Definitions and reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP are included below.

(2)Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022.

*Bookings -* We define bookings as the total value of contract awards received from the U.S. government for which it has appropriated funds and legally obligated such funds to the Company through a contract or purchase order, plus the value of contract awards and orders received from customers other than the U.S. government.

*Backlog* - We define Backlog to include the following components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Funded - Funded backlog represents the revenue value of orders for services under existing contracts for which funding is appropriated or otherwise authorized less revenue previously recognized on these contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Unfunded - Unfunded backlog represents the revenue value of firm orders for products and services under existing contracts for which funding has not yet been appropriated less funding previously recognized on these contracts.

The following table summarizes the value of our backlog, at the respective dates presented:

*Backlog:*

---

| | | | |
|:---|:---|:---|:---|
| | **December 31,** | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Backlog: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Funded<sup>(1)</sup> | $2510 | $2847 | $2547 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unfunded<sup>(1)</sup> | 351 | 444 | 297 |
| **Total backlog**<sup>(1)</sup>  | $2861 | $3291 | $2844 |

---

________________

(1)See Part I, Item 1A. "Risk Factors—Risks Relating to Our Business—We may not realize the full value of our total estimated contract value or bookings, including as a result of reduction of funding or cancellation of our U.S. government contracts, which could have a material adverse impact on our business, financial condition and results of operations" in this Annual Report.

***Non-GAAP Financial Measures***

We believe the non-GAAP financial measures presented in this document will help investors understand our financial condition and operating results and assess our future prospects. We believe these non-GAAP financial measures, each of which is discussed in greater detail below, are important supplemental measures because they exclude unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of our ongoing operating results. Further, when read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as a tool to help make financial, operational and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry by providing more comparable measures that are less affected by factors such as capital structure.

We recognize that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. In order to compensate for these and the other limitations discussed below, management does not consider these measures in

------

**Exhibit 99.1**

isolation from or as alternatives to the comparable financial measures determined in accordance with U.S. GAAP. Readers should review the reconciliations below and should not rely on any single financial measure to evaluate our business.

We define these non-GAAP financial measures as:

*Adjusted EBITDA and Adjusted EBITDA Margin* - We define Adjusted EBITDA as our net earnings before income taxes, amortization of acquired intangible assets, depreciation, restructuring costs, interest, deal related transaction costs, acquisition and divestiture related expenses, foreign exchange, COVID-19 response costs, non-service pension expenditures and other one-time non-operational events. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by revenue. Adjusted EBITDA and Adjusted EBITDA Margin are not measures calculated in accordance with U.S. GAAP, and they should not be considered an alternative to any financial measures that were calculated under U.S. GAAP. Adjusted EBITDA and Adjusted EBITDA Margin are used to facilitate a comparison of the ordinary, ongoing and customary course of our operations on a consistent basis from period to period and provide an additional understanding of factors and trends affecting our business. Adjusted EBITDA and Adjusted EBITDA Margin are driven by changes in volume, performance, contract mix and general and administrative expenses and investment levels. Performance, as used in this definition, refers to changes in profitability and is primarily based on adjustments to estimates at completion on individual contracts. These adjustments result from increases or decreases to the estimated value of the contract, the estimated costs to complete the contract, or both. These measures therefore assist management and our board and may be useful to investors in comparing our operating performance consistently over time as they remove the impact of our capital structure, asset base and items outside the control of the management team and expenses that do not relate to our core operations. Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to similarly titled non-GAAP measures used by other companies as other companies may have calculated the measures differently. The reconciliation of Adjusted EBITDA to net earnings is provided below:

*Consolidated Entity Adjusted EBITDA Reconciliation:*

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Net earnings | $154 | $85 | $75 |
| Income tax provision | 46 | 27 | 20 |
| Amortization of intangibles | 9 | 9 | 9 |
| Depreciation | 49 | 44 | 42 |
| Restructuring costs | 5 | 12 | 20 |
| Interest expense | 35 | 64 | 65 |
| Deal related transaction costs | 5 | 9 |  |
| Foreign exchange | 1 | 1 |  |
| COVID-19 response costs | 6 | 12 |  |
| Non-service pension expense |  | 5 | 3 |
| Other one-time non-operational events |  |  |  |
| Adjusted EBITDA | $310 | $268 | $234 |

---

*Adjusted EPS* – We calculate Adjusted EPS by excluding deal related transaction costs, acquisition and divestiture related expenses and COVID-19 response costs from our net earnings (loss) to arrive at Adjusted EPS. We believe that Adjusted EPS allows investors to effectively compare our core performance from period to period by excluding items that are not indicative of, or are unrelated to, results from our ongoing business operations such as our capital structure, significant non-cash expenses, the impacts of financing decisions on earnings, and items incurred outside the ordinary, ongoing and customary course of our business. Adjusted EPS has limitations as an analytical tool and does not

------

**Exhibit 99.1**

represent, and should not be considered an alternative to basic or diluted EPS as determined in accordance with U.S. GAAP. The reconciliation of Adjusted EPS to U.S. GAAP EPS is shown below:

*Consolidated Entity Reconciliation of Adjusted EPS:*

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions, except per share amounts)* | **2021** | **2020** | **2019** |
| Net earnings | $154 | $85 | $75 |
| Deal related transaction costs | 5 | 9 |  |
| COVID-19 response costs | 6 | 12 |  |
| Adjusted net earnings | $165 | $106 | $75 |
| Basic EPS<sup>(1)</sup> | $0.73 | $0.40 | $0.36 |
| Adjusted EPS <sup>(1)</sup> | $0.78 | $0.50 | $0.36 |

---

________________

(1)Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022.

*Leverage Ratio* - We define our leverage ratio as total net debt divided by Adjusted EBITDA. Net debt includes debt related to financing lease obligations net of balance sheet cash and cash equivalents and related party note receivables.

The table below provides the calculation of the Leverage Ratio as of December 31, 2021, 2020 and 2019.

---

| | | | |
|:---|:---|:---|:---|
| | **Year End December 31,** | **Year End December 31,** | **Year End December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Long-term debt | $352 | $374 | $656 |
| Short-term borrowings and current portion of long-term debt | 41 | 53 | 56 |
| Cash and cash equivalents | (240) | (61) | (85) |
| Related party note receivable |  | (115) | (100) |
| Total net debt | $153 | $251 | $527 |
| Adjusted EBITDA | $310 | $268 | $234 |
| Leverage Ratio | 0.5 x | 0.9 x | 2.3 x |

---

*Free Cash Flow* – We define free cash flow as the sum of the cash flows provided by operating activities and the cash flows provided by (used in) investing activities pertaining to capital expenditures and proceeds generated from the sale of capital assets.

We believe that free cash flow provides management and investors with an important measure of our ability to generate cash on a normalized basis. Free cash flow also provides insight into our flexibility to allocate capital and pursue opportunities that may enhance shareholder value. We believe that while expenditures and dispositions of property plant and equipment will fluctuate period to period, we seek to ensure that we have adequate capital on hand to maintain ongoing operations and enable growth of the business. Additionally, free cash flow is of limited usefulness, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact the measures do not deduct the payments required for debt service and other contractual obligations or payments. The reconciliation between free cash flow and net cash provided by operating activities (the most comparable U.S. GAAP measure) is shown below:

------

**Exhibit 99.1**

*Consolidated Entity Reconciliation of Free Cash Flow:*

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Net cash provided by operating activities | $178 | $125 | $157 |
| Capital expenditures | (60) | (56) | (55) |
| Proceeds from sales of assets |  | 5 | 8 |
| Free cash flow | $118 | $74 | $110 |

---

**Factors Impacting Our Performance**

***U.S. Government Spending and Federal Budget Uncertainty***

Changes in the volume and relative mix of U.S. government spending as well as areas of spending growth could impact our business and results of operations. In particular, our results can be affected by shifts in strategies and priorities on homeland security, intelligence, defense-related programs, infrastructure and urbanization and continued increased spending on technology and innovation, including cybersecurity, artificial intelligence, connected communities and physical infrastructure (for example, the potential impact for the Russia / Ukraine conflict). Cost-cutting and efficiency initiatives, current and future budget restrictions, spending cuts and other efforts to reduce government spending and shifts in overall priorities (for example, in response to the COVID-19 pandemic) could cause our government customers to reduce or delay funding or invest appropriated funds on a less consistent basis or not at all, and demand for our solutions or services could diminish. Furthermore, any disruption in the functioning of government agencies, including as a result of government closures and shutdowns, could have a negative impact on our operations and cause us to lose revenue or incur additional costs due to, among other things, our inability to maintain access and schedules for government testing or deploy our staff to customer locations or facilities as a result of such disruptions.

There is also uncertainty around the timing, extent, nature and effect of Congressional and other U.S. government actions to address budgetary constraints, caps on the discretionary budget for defense and non-defense departments and agencies, and the ability of Congress to determine how to allocate the available budget authority and pass appropriations bills to fund both U.S. government departments and agencies that are, and those that are not, subject to the caps. Additionally, budget deficits and the growing U.S. national debt, including as a result of legislative actions in response to the COVID-19 pandemic, may increase pressure on the U.S. government to reduce federal spending across all federal agencies, with uncertainty about the size and timing of those reductions. Furthermore, delays in the completion of future U.S. government budgets could in the future delay procurement of the federal government services we provide. A reduction in the amount of, or reductions, delays, or cancellations of funding for, services that we are contracted to provide to the U.S. government as a result of any of these impacts or related initiatives, legislation or otherwise could have a material adverse effect on our business and results of operations. See Part I. Item 1A. "Risk Factors—Risks Related to Our Business—Significant delays or reductions in appropriations for our programs and changes in U.S. government priorities and spending levels more broadly may negatively impact our business and could have a material adverse impact on our business, financial condition and results of operations" and Part I. Item 1A. "Risk Factors—Risks Related to Our Business—The COVID-19 pandemic and related impacts have had and are likely to continue to have an adverse impact on our business, financial condition and results of operations." Please see also Part II. Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations—Business Overview and Considerations—Business Environment" in this Annual Report for further details on U.S. government spending's impact on our business.

***Operational Performance on Contracts***

Revenue, earnings (margin) and the timing of our cash flows depend on our ability to perform on our contracts. When agreeing to contractual terms, our management team makes assumptions and

------

**Exhibit 99.1**

projections about future conditions and events. The accounting for our contracts and programs requires assumptions and estimates about these conditions and events. These projections and estimates assess:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the productivity and availability of labor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the allocation of indirect costs to labor and material costs incurred

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the complexity of the work to be performed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the cost and availability of materials and components; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• schedule requirements.

If there is a significant change in one or more of these circumstances, estimates or assumptions, or if the risks under our contracts are not managed adequately, the profitability of contracts could be adversely affected. This could affect earnings and margin materially.

In particular, profitability can fluctuate predicated on the type of contract awarded. Typically fixed-price development programs on complex systems represent a higher risk profile to complete on-budget. To the extent our fixed-price development efforts create a larger portion of our revenue output, this may result in reduced operating margins given the higher risk profile. The following represents the impact that changing certain of our estimates, particularly those regarding our fixed-price development programs, would have had have on our revenues:

*Impact of Change in Estimates on our Revenue Results*

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Revenue | $(34) | $(77) | $(55) |
| Total % of Revenue | 1% | 3% | 2% |

---

Additionally, the timing of our cash flows is impacted by the timing of achievement of billable milestones on contracts. Historically, this has resulted and could continue to result in fluctuations in working capital levels and quarterly free cash flow results. As a result of such quarterly fluctuations in free cash flow results, we believe that quarter-to-quarter comparisons of our results of operations may not necessarily be meaningful and should not be relied upon as indicators of future performance.

***Regulations***

Increased audit, review, investigation and general scrutiny by U.S. government agencies of performance under government contracts and compliance with the terms of those contracts and applicable laws could affect our operating results. Negative publicity and increased scrutiny of government contractors in general, including us, relating to government expenditures for contractor services and incidents involving the mishandling of sensitive or classified information as well as the increasingly complex requirements of the DoD and the United States intelligence community, including those related to cybersecurity, could impact our ability to perform in the markets we serve.

***International Sales***

International revenue, including foreign military sales, foreign military financing, and direct commercial sales, accounted for approximately 5%, 8% and 4% of our revenue for the years ended December 31, 2021, 2020 and 2019., respectively. Since our focus is primarily with the DoD and our investments are focused as such, we anticipate that international sales will continue to account for a similar percentage of revenue in the future. We remain subject to the spending levels, pace and priorities of the U.S. government as well as international governments and commercial customers, and to general economic conditions that could adversely affect us, our customers and our suppliers.

------

**Exhibit 99.1**

Additionally, some international sales may expose us to foreign exchange fluctuations and changing dynamics of foreign competitiveness based on variations in the value of the U.S. dollar relative to other currencies. The impact of those fluctuations is reflected throughout our Consolidated Financial Statements, but in the aggregate, did not have a material impact on our results of operations for the years ended December 31, 2021, 2020 and 2019.

***Acquisitions & Divestitures***

We consider the acquisition of businesses and investments that we believe will expand or complement our current portfolio and allow access to new customers or technologies. We also may explore the divestiture of businesses that no longer meet our needs or strategy or that could perform better outside of our organization.

During the third quarter of 2021 the Company acquired substantially all the assets of Ascendant Engineering Solutions (AES), an advanced gimbal producer located in Austin, TX. The purchase closed on July 28, 2021 for a purchase price of $11 million with an additional $5 million payable upon the achievement of certain financial and operational targets.

AES designs, develops and manufactures high-performance, stabilized, multi-sensor gimbal systems for the growing market of Group 1, 2 and 3 unmanned aerial systems (UAS) serving several branches of the DoD. The company is focused on gimbal payload opportunities in strategic U.S. government programs including those intended to counter current and next-generation anti-access and area-denial systems. We believe this acquisition enables the integration of our own Electro-Optical and Infrared systems with the gimbals of AES and is a strategic investment, offering an integrated solution for our customers in the market for lightweight military platforms including small unmanned aerial systems. The acquisition has been accounted for as a business combination and has been integrated into our Advanced Sensing and Computing segment.

On March 21, 2022, the Company entered into a definitive agreement to sell its Global Enterprise Solutions (GES) business to SES Government Solutions, Inc., a wholly-owned subsidiary of SES S.A., for $450 million in cash, which was completed on August 1, 2022. GES, which was part of the ASC segment, provides commercial satellite communications to the U.S. Government and delivers satellite communications and security solutions to customers worldwide. SES S.A. has guaranteed the payment of the purchase price and performance of all other obligations of SES Government Solutions, Inc. under the agreement.

**Components of Operations**

***Revenue***

Revenue consists primarily of product related revenue, generating 87% ,87% and 82% of our total revenues for the periods ended December 31, 2021, 2020 and 2019, respectively. The remaining revenue is generated from service related contracts. Additionally, 87%, 87% and 86% of our revenue generation for December 31, 2021, 2020 and 2019, respectively, is derived from firm-fixed priced contracts. For a firm-fixed price contract, customers agree to pay a fixed amount, negotiated in advance, for a specified scope of work. Revenue on fixed price contracts is generally recognized over time using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying our performance obligations. Incurred costs represent work performed that corresponds with and thereby best depicts the transfer of control to the customer.

Under flexibly priced contracts, which consists of 13%,13% and 14% of our total revenues for December 31, 2021, 2020 and 2019, respectively, we are reimbursed for allowable or otherwise defined total costs (defined as cost of revenues plus allowable general and administrative expenses) incurred, plus a fee. The contracts may also include incentives for various performance criteria, including quality, timeliness, cost-effectiveness or other factors. In addition, costs are generally subject to review by clients and regulatory audit agencies, and such reviews could result in costs being disputed as non-reimbursable

------

**Exhibit 99.1**

under the terms of the contract. Revenue for flexibly priced contracts are generally recognized as services are performed and are contractually billable.

Please refer to "Part II. Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates" and "Note 2: Revenue from Contracts with Customers" in the Notes to our Consolidated Financial Statements.

***Cost of Revenues***

Cost of revenues includes materials, labor and overhead costs incurred in the manufacturing, design, and provision of products and services sold in the period as well as warranty costs. Material costs include raw materials, purchased components and sub-assemblies and outside processing and inbound freight. Labor and overhead costs consist of direct and indirect manufacturing costs, including wages and fringe benefits, operating supplies, depreciation and amortization, occupancy costs, and purchasing, receiving, inspection costs and inbound freight costs.

***General and Administrative Expenses***

General and administrative expenses include general and administrative expenses not included within cost of revenues such as salaries, wages and fringe benefits, facility costs and other costs related to these indirect functions. Additionally, general and administrative expenses include internal research and development costs as well as expenditures related to bid and proposal efforts.

**Results from Operations**

The following discussion of operating results is intended to help the reader understand the results of operations and financial condition of the Company, as well as individual segments, for the year ended December 31, 2021 as compared to the year ended December 31, 2020, and for the year ended December 31, 2020 compared to December 31, 2019. Given the nature of our business, we believe revenue and earnings from operations are most relevant to an understanding of our performance at a business and segment level. Our operating cycle is lengthy and involves various types of production

------

**Exhibit 99.1**

contracts and varying delivery schedules. Accordingly, operating results in a particular year may not be indicative of future operating results.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** | **2021 vs. 2020 Variance** | **2020 vs. 2019 Variance** |
| (Dollars in millions, except per share amounts) | **2021** | **2020** | **2019** | $% | $% |
| Total revenues | $2879 | $2778 | $2714 | 3.6% | 2.4% |
| Total cost of revenues | (2332) | (2284) | (2255) | 2.1% | 1.3% |
| Gross profit | $547 | $494 | $459 | 10.7% | 7.6% |
| Gross margin | 19.0% | 17.8% | 16.9% | 6.8% | 5.1% |
| General and administrative expenses | (293) | (283) | (277) | 3.5% | 2.2% |
| Amortization of intangibles | (9) | (9) | (9) | —% | —% |
| Other operating expenses, net | (9) | (21) | (10) | (57.1)% | 110.0% |
| Operating earnings | $236 | $181 | $163 | 30.4% | 11.0% |
| Interest expense | (35) | (64) | (65) | (45.3)% | (1.5)% |
| Other, net | $(1) | (5) | (3) | (80.0)% | 66.7% |
| Earnings before taxes | $200 | $112 | $95 | 78.6% | NM |
| Income tax provision | 46 | 27 | 20 | 70.4% | NM |
| Net earnings | $154 | $85 | $75 | 81.2% | NM |
| Shares outstanding<sup>(1)</sup> | 210 | 210 | 210 | —% | —% |
| Basic EPS<sup>(1)</sup> | $0.73 | $0.40 | $0.36 | 81.2% | NM |
| Diluted EPS<sup>(1)</sup> | $0.73 | $0.40 | $0.36 | 81.2% | NM |
| Adjusted EPS <sup>(1)(2)</sup> | $0.78 | $0.50 | $0.36 | 55.7% | NM |
| Adjusted EBITDA<sup>(2)</sup> | $310 | $268 | $234 | 15.7% | 14.5% |
| Adjusted EBITDA Margin<sup>(2)</sup> | 10.8% | 9.6% | 8.6% | 11.6% | 11.9% |
| Backlog<sup>(2)</sup> | 2861 | 3291 | 2844 | (13.1)% | 15.7% |
| Total net debt | 153 | 251 | 527 | (39.0)% | (52.4)% |
| Leverage Ratio<sup>(2)</sup> | 0.5x | 0.9x | 2.3x | (44.4)% | (62.2)% |
| Bookings<sup>(2)</sup> | 2595 | 3055 | 2923 | (15.1)% | 4.5% |
| Free cash flow<sup>(2)</sup> | $118 | $74 | $110 | 59.5% | (32.7)% |

---

______________

NM- percentage change not meaningful

(1)Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022.

(2)See Part II. Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations—Key Financial and Operating Measures—Non-GAAP Financial Measures" above for definitions of these measures. Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin, Leverage Ratio, and free cash flow are non-GAAP measures. See Part II. Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations—Key Financial and Operating Measures—Non-GAAP Financial Measures" above for reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.

(3)See Part I. Item 1A. "Risk Factors—Risks Relating to Our Business—We may not realize the full value of our total estimated contract value or bookings, including as a result of reduction of funding or cancellation of our U.S. government contracts, which could have a material adverse impact on our business, financial condition and results of operations" in this Annual Report.

------

**Exhibit 99.1**

**Year Ended December 31, 2021 Compared to the Years Ended December 31, 2020 and *December 31, 2019***

***Year Ended December 31, 2021 Compared With Year Ended December 31, 2020***

Our operating results for the year ended December 31, 2021 are highlighted by our financial performance including strong margin expansion, free cash flow generation and continued revenue growth, all while we continuing to combat the impacts of the global pandemic. Revenue of $2,879 million for the year ended December 31, 2021 represented year over year growth of $101 million (3.6%) while our operating earnings and net earnings grew $55 million (30.4%) and $69 million (81.2%) from the year ended December 31, 2020, respectively. Along with our net earnings expansion, Adjusted EBITDA, one of our key operational evaluation metrics, increased $42 million, or 15.7%, from the prior year to $310 million, representing our third straight year of double digit Adjusted EBITDA growth. The Adjusted EBITDA growth drove Adjusted EBITDA margins to 10.8%, a 120 bps increase from 2020. Additionally we increased our cash generation by 59%. For more detailed operational explanations, please see financial analysis below. Our backlog of $2.9 billion at December 31, 2021 represents a a diversified, balanced portfolio supported by foundational programs strongly aligned in areas of, in our view, growing importance within the DoD budget priorities. Our backlog position is highlighted by the recent awards received on next generation Airborne Force Protection and Dismounted Soldier Sensing programs at our ASC segment, production contracts received to provide propulsion system and electrical components on the Columbia-class submarine and CVN Carrier Class programs at our IMS segment and our legacy positions within our ASC segment including our flagship Mounted Family of Computer Systems ("MFoCS") ruggedized computing and battle management system, Global Access Network and naval network and hardware programs. We believe the performance on these and other programs within our portfolio will support continued revenue growth while the transition from development efforts to production will continue our trend of earnings growth and margin expansion.

***Year Ended December 31, 2020 Compared With Year Ended December 31, 2019***

Our operating results for the year ended December 31, 2020 are highlighted by another successful year of revenue growth and margin expansion despite COVID-19 related operational challenges throughout the year. Revenue of $2,778 million for the year ended December 31, 2020 represented year over year growth of $64 million (2.4%) while our operating earnings and net earnings grew $18 million (11.0%) and $10 million (13.3%) from the year ended December 31, 2019, respectively. Along with our net earnings expansion, Adjusted EBITDA, one of our key operational evaluation metrics, increased $34 million, or 14.5%, from the prior year to $268 million, representing our second straight year of double digit Adjusted EBITDA annual growth. The Adjusted EBITDA growth drove Adjusted EBITDA margins to 9.6%, a 1.0% increase from 2019. For more detailed operational explanations, please see financial analysis below.

In addition, our diversified, balanced portfolio supported by foundational programs with strong, visible backlog aligned in areas of, in our view, growing importance within the DoD budget priorities, resulted in remaining contract value of $3.3 billion, driven by our awards and positions on existing platforms. Our recent awards include supporting Counter Unmanned Aircraft Systems ("CUAS") efforts with the U.S. Army and continued success in receiving next generation Force Protection and Dismounted Soldier Sensing programs with both the U.S. Army and U.S. Navy at our ASC segment. Our positions include providing propulsion systems components on the Columbia-class submarine at our IMS segment and our legacy positions on our Mounted Family of Computer Systems ("MFoCS") and Global Access Network programs at our ASC segment. We believe these programs will support continued revenue and margin growth as programs transition from development efforts to production, continuing our trend of earnings growth and margin expansion.

------

**Exhibit 99.1**

***Revenue***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

For the year ended December 31, 2021, Revenue increased by $101 million, or 3.6%, to $2,879 million from $2,778 million for year ended December 31, 2020. The revenue growth in 2021 was primarily due to an increase of $126 million at our IMS segment, driven by contracted efforts to provide the U.S. Army with Mission Equipment Packages to support mobile short range air defense capabilities ($158 million) and continued progress providing power conversion equipment and electrical components and systems to the U.S. Navy to support the CVN 80/81 carrier ($72 million) and Columbia Class programs ($36 million). The IMS revenue growth was partially offset by the completion of the urgent operational needs TROPHY<sup>TM</sup> APS program ($93 million) which realized significant production efforts in 2020. Offsetting the IMS results was a $18 million revenue decrease at our ASC segment attributed primarily to a reduction in naval electronics hardware programs and bandwidth demands on certain global network programs, partially offset by a ramp up of full-rate production efforts on next generation dismounted soldier targeting systems with the U.S. Army ($37 million).

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Revenue increased by $64 million, or 2.3%, to $2,778 million for year ended December 31, 2020 from $2,714 million for year ended December 31, 2019. The revenue growth in 2020 was primarily due to an increase of $148 million at our ASC segment, driven by programs transitioning from development to production and increased deliveries in our Dismounted Soldier Sensing and Targeting Systems programs, resulting in a $109 million increase as compared to the prior year. The ASC segment also realized annual revenue expansion through progress on our recently awarded program to provide electric control systems for the U.S. Navy's shipboard launch system ($22 million) and pilot training programs ($29 million). Additionally, the ASC segment continued progress in our Satellite & Network Communications programs and ruggedized maintenance support hardware programs contributed $28 million and $29 million, respectively, of incremental revenue as compared to 2019. These contributions were partially offset by certain naval common network services equipment programs in which we made strategic decisions to allocate capital in what we believe are more profitable opportunities. At our IMS segment, our continued market penetration on CUAS opportunities drove $28 million of incremental revenue during 2020 as compared to 2019. In addition, our recently awarded programs to provide power solutions on the CVN 80/81 carriers and logistics support equipment to the Israel Ministry of Defense contributed revenue of $14 million and $13 million, respectively. However, despite this success, our IMS revenue growth was more than offset by a decline of $160 million compared to 2019 attributable to accelerated deliveries of our TROPHY™ APS program in the prior year.

***Cost of Revenues***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Cost of revenues increased $48 million, or 2.1%, from $2,284 million to $2,332 million for the year ended December 31, 2021, primarily due to the 3.7% increase in revenue as described above. The cost of revenues growth was favorably offset by improved program performance on certain of our development programs as they transition from development to production. The improved programmatic performance is highlighted by our electrical components and system programs with the U.S. Navy on the Columbia Class program. Despite the improved program performance however we did realize adjustments on cost at completion estimates which negatively impacted earnings with charges totaling 1% of revenue for the period ended December 31, 2021; see *Note 2: Revenue from Contracts with Customers* for further detail.

------

**Exhibit 99.1**

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues increased $29 million, or 1.3%, from $2,255 million to $2,284 million for the year ended December 31, 2020, primarily due to increased revenue as described above. The cost of revenues growth was favorably offset by improved program mix, with our higher profit segment, ASC, driving the year over year revenue expansion as noted above. Please see "—Review of Operating Segments" below for further discussion. The favorable impact of program mix was partially offset by changes in estimates to complete certain development related programs at our IMS segment of $46 million and at our ASC segment of $19 million; see **Note 2***:* **Revenue from Contracts with Customers** for further detail.

***Gross Profit***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Gross profit increased $53 million, or 10.7%, from $494 million for the year ended December 31, 2020 to $547 million for the year ended December 31, 2021, primarily driven by revenue growth and favorable program performance, including the improved execution on the Columbia Class program efforts as noted above.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Gross profit increased $35 million, or 7.6%, from $459 million for the year ended December 31, 2019 to $494 million for the year ended December 31, 2020, primarily driven by revenue growth and favorable program mix as noted above, offset by the charges realized on development type programs at our IMS segment of $47 million and a reduction in the estimated amount of variable consideration related to certain claims on electronics programs with the U.S. Navy totaling $11 million.

***General and Administrative Expenses***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

General and administrative expenses increased by $10 million, or 3.5%, from $283 million for the year ended December 31, 2020 to $293 million for the year ended December 31, 2021, resulting primarily from increases in discretionary investment of $7 million related to Independent Research and Development (IR&D). Additionally we realized a slight increase in General and Administrative spend driven by increased travel costs and medical expenses when compared to the prior year where we experienced a reduction in these costs as a result of the COVID-19 Pandemic. These costs were partially offset by a reduction in deal related transaction costs which peaked in 2020 with preparation for a potential public offering.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

General and administrative expenses increased by $6 million, or 2.2%, from $277 million for the year ended December 31, 2019 to $283 million for the year ended December 31, 2020, resulting from increases in discretionary investment of $9 million for both Independent Research and Development (IR&D) and Bid and Proposal (B&P) costs, as well as $9 million in expenses related to our planned initial public offering. These costs were partially offset by reductions in corporate, employee medical and travel expenditures related to certain of the impacts of COVID-19 on our business.

***Other Operating Expenses, Net***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Other operating expenses decreased by $12 million to $9 million for the year ended December 31, 2021 from $21 million for the year ended December 31, 2020, mainly due to lower restructuring costs and a reduction in costs incurred in response to impacts of the COVID-19 pandemic. In total we incurred $7

------

**Exhibit 99.1**

million of expenditures related to COVID-19 from January 1, 2021 through December 31, 2021, compared to $12 million from March 1, 2020 to December 31, 2020, to ensure a safe work environment for our employees. These costs included paid leave, personal protective equipment and other cleaning measures, and social and physical distancing efforts including the use of zones and subzones for manufacturing facilities. Please see "—Business Overview and Considerations—Impacts of COVID-19 On Our Business" for further details on COVID-19 impact on our business.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Other operating expenses increased by $11 million to $21 million for the year ended December 31, 2020 from $10 million for the year ended December 31, 2019, mainly due to costs incurred in response to impacts of the COVID-19 pandemic. In total we incurred $12 million of expenditures from March 1, 2020 through December 31, 2020 to ensure a safe work environment for our employees. These costs included paid leave, personal protective equipment and other cleaning measures, facility filtration systems and social and physical distancing efforts, including the use of zones and subzones for manufacturing facilities. Please see "—Business Overview and Considerations—Impacts of COVID-19 On Our Business" for further details on COVID-19 impact on our business.

***Amortization of Intangibles***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Amortization of intangibles for the year ended December 31, 2021 of $9 million were consistent with the year ended December 31, 2020.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Amortization of intangibles for the year ended December 31, 2020 of $9 million were consistent with the year ended December 31, 2019.

***Operating Earnings***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Operating earnings increased by $55 million to $236 million, or 30.4%, for the year ended December 31, 2021 from $181 million for the year ended December 31, 2020, driven by the increased revenue output and related contribution margin as well as improved program performance driven by improved performance at our IMS segment as noted above.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Operating earnings increased by $18 million to $181 million, or 11.0%, for the year ended December 31, 2020 from $163 million for the year ended December 31, 2019, driven by the increased revenue and related contribution margin resulting from our ASC segment noted above, offset by the aforementioned changes in estimates to complete at our IMS and ASC segments, which led to an increase in general and administrative expenses and other operating expenditures.

***Interest Expense***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Interest expense decreased by $29 million to $35 million for year end December 31, 2021 from $64 million for the year ended December 31, 2020. The reduction in annual interest was primarily attributed to the $300 million of forgiveness of principal on our 7.5% Term Loan debt that occurred in December 2020. The weighted average interest rate on our revolving credit facility was 3.67% in 2021 compared to 4.36% in 2020. see Note 11*: Debt* for further detail.

------

**Exhibit 99.1**

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Interest expense decreased by $1 million to $64 million for year end December 31, 2020 from $65 million for the year ended December 31, 2019. The reduction in annual interest was attributed to the lower interest rates on our variable rate borrowings. The weighted average interest rate on our revolving credit facility was 4.36% in 2020 compared to 5.93% in 2019.

***Other, Net***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Other, net decreased to $1 million for the year ended December 31, 2021 from $5 million for the year ended December 31, 2020. This was primarily related to a loss realized on the termination on one of our international defined benefit pension plans recorded in the year ended December 31, 2020.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Other, net increased to $5 million for the year ended December 31, 2020 from $3 million for the year ended December 31, 2019. This was primarily related to a loss of the termination on one of our international defined benefit pension plans.

***Earnings (Loss) Before Taxes***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Earnings before taxes increased by $88 million to $200 million for the year ended December 31, 2021 from $112 million for the year ended December 31, 2020. This was primarily due to increased operating earnings of $55 million, the reduction of $29 million in interest expenditures and a reduction in other, net costs of $4 million as described above.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Earnings (loss) before taxes increased by $17 million to $112 million for the year ended December 31, 2020 from $95 million for the year ended December 31, 2019. This was primarily due to increased operating earnings of $18 million, the reduction of $1 million in interest expenditures offset in part by the $2 million increase of other, net costs as described above.

***Income Tax Provision (Benefit)***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Income tax provision increased by $19 million to $46 million for the year ended December 31, 2021 from $27 million for the year ended December 31, 2020. This was primarily due to an increase in earnings before taxes. Our effective tax rate for 2021 was 23.0% compared to 24.1% in 2020. The decrease in the effective tax rate is primarily attributable to a decrease in non-deductible costs in connection with planned deal related expenditures of $9 million incurred during 2020.

As of December 31, 2021 the Company had $28 million of Federal net operating loss carryforwards and $23 million of net tax credit carry-forwards that can be utilized to reduce approximately $30 million of future tax liabilities prior to their expiration commencing in 2025.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Income tax provision (benefit) increased by $7 million to $27 million for the year ended December 31, 2020 from $20 million for the year ended December 31, 2019. This was primarily due to an increase in earnings before taxes. Our effective tax rate for 2020 was 24.1% compared to 21.1% in 2019. The increase in the effective tax rate is primarily attributable to non-deductible costs in connection with our planned initial public offering of $9 million incurred during 2020.

------

**Exhibit 99.1**

As of December 31, 2020 the Company had $131 million of Federal net operating loss carryforwards and $23 million of net tax credit carry-forwards that can be utilized to reduce approximately $50 million of future tax liabilities prior to their expiration commencing in 2025.

***Net Earnings***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Net earnings increased by $69 million to $154 million for the year ended December 31, 2021 when compared to the year ended December 31, 2020. This was driven by increased earnings before taxes of $88 million offset by an increased income tax provision of $19 million as described above.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Net earnings (loss) increased by $10 million to $85 million for the year ended December 31, 2020 when compared to the year ended December 31, 2019. This was driven by increased earnings before taxes of $17 million offset by increased in income tax provision of $7 million as described above.

***Basic and Diluted EPS***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

For the year ended December 31, 2021, there were no changes in the number of basic and diluted shares. No equity awards were issued during such year. As of December 31, 2021 and 2020, there were 210,445,073 shares of common stock outstanding (after giving effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022), resulting in a basic and diluted EPS of $0.73 and $0.40 per share for the years ended December 31, 2021 and 2020, respectively. The increase in EPS is attributed to the net earnings growth described above.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

For the year ended December 31, 2020, there were no changes in the number of basic and diluted shares. No equity awards were issued during such year. As of December 31, 2020 and 2019, there were 145,000,000 shares of common stock outstanding (after giving effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022 , resulting in a basic and diluted EPS of $0.40 and $0.36 per share for the years ended December 31, 2020 and 2019, respectively. The increase in EPS is attributed to the net earnings growth described above.

***Adjusted EBITDA***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Adjusted EBITDA increased $42 million, or 15.7%, from $268 million for the year ended December 31, 2020 to $310 million for the year ended December 31, 2021, primarily due to the increased gross profit contribution attributed to revenue growth and favorable program performance improvements.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Adjusted EBITDA increased $34 million, or 14.5%, from $234 million for the year ended December 31, 2019 to $268 million for the year ended December 31, 2020, primarily due to the increased gross profit contribution attributed to revenue growth and favorable revenue mix.

------

**Exhibit 99.1**

***Adjusted EBITDA Margin***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Adjusted EBITDA Margin increased 120 bps from 9.6% for the year ended December 31, 2020 to 10.8% for year ended December 31, 2021. This was primarily due to gross margin expansion attributable to favorable program performance realized at our IMS segment driven by our Columbia Class efforts as noted above.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Adjusted EBITDA Margin increased from 8.6% for the year ended December 31, 2019 to 9.6% for year ended December 31, 2020. This was primarily due to gross margin expansion attributable to favorable mix from increased revenues from our higher margin ASC segment.

***Adjusted EPS***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

For the year ended December 31, 2021, there were no changes in the number of basic and diluted shares. No equity awards were issued during such year. As of December 31, 2021 and 2020, there were 210,445,073 shares of common stock outstanding (after giving effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022), resulting in adjusted EPS of $0.78 and $0.50 per share, respectively. The increase in EPS is attributed to the net earnings growth as compared to 2020.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

For the year ended December 31, 2020, there were no changes in the number of basic and diluted shares. No equity awards were issued during such year. As of December 31, 2020 and 2019, there were 145,000,000 shares of common stock outstanding (after giving effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021 and a 1.451345331-for-1 forward stock split on our common stock effected November 23, 2022), resulting in adjusted EPS of $0.50 and $0.36 per share, respectively. The increase in EPS is attributed to the net earnings growth noted above as well as COVID-19 response expenses and IPO related expenditures incurred in 2020.

***Backlog***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Backlog decreased by $(430) million, or (13.1)%, from $3,291 million as of December 31, 2020 to $2,861 million as of December 31, 2021. The backlog decrease was driven by our progress on our Naval Programs within our IMS segment. Please see "—Review of Operating Segments" below for a more detailed analysis.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Backlog increased by $447 million, or 15.7%, from $2,844 million as of December 31, 2019 to $3,291 million as of December 31, 2020. The backlog increase was driven by our IMS segment, primarily attributed to the receipt of multi-year funding awards received on our naval power and propulsion programs. Please see "—Review of Operating Segments" below for a detailed analysis.

------

**Exhibit 99.1**

***Leverage Ratio***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

For year ended December 31, 2021, our leverage ratio decreased to 0.5x from 0.9x for the year ended December 31, 2020. This was driven by improved Adjusted EBITDA of $42 million as compared to 2020 and the reduction in our net debt of $98 million as compared to the prior year. The net debt reduction was a result of the free cash flow generated during the period less amounts paid to acquire the strategic acquisition of Ascendant Engineering Solutions, LLC ("AES").

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

For year ended December 31, 2020, our leverage ratio decreased to 0.9x from 2.3x for the year ended December 31, 2019. This was driven by improved Adjusted EBITDA of $34 million as compared to 2019 and the reduction in our net debt of $276 million as compared to the prior year. The net debt reduction was a result of the forgiveness of $300 million related party debt by US Holding and the repayment of certain related party debt obligations of $65 million, partially offset by the commencement of certain long-term finance leases and other financing obligations of $84 million.

***Bookings***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Our business cycle is such that program allocated funding that supports our bookings is largely funded incrementally to support 12 - 15 months of revenue output, depending on the program. Throughout the fiscal years ended December 31, 2019 and 2020, we realized a surge in multi-year funding of programs that has impacted our bookings trend for the period ended December 31, 2021 but allows for our continued revenue growth. For the cumulative three-year period ended December 31, 2021 we have realized new awards totaling $8,573 million while generating revenue of $8,371 million a ratio of greater than 1:1. For the year ended December 31, 2021, we generated bookings of $2,595 million, 15.1% less than the $3,055 million realized during the year ended December 31, 2020. The decrease, as noted above, was anticipated as significant multi-year production awards were received during the year ended December 31, 2020. The multi-year production awards realized in 2020 includes the receipt of multi-year funding received on our naval power and propulsion programs to support the CVN 80/81 carriers program and production awards for next generation Dismounted Soldier Sensing and Airborne Force Protection programs with the U.S. Army, which reduced annual bookings by $210 million and $193 million respectively.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Bookings increased to $3,055 million, or 4.5%, for the year ended December 31, 2020 from $2,923 million for the year ended December 31, 2019. The increase was driven by significant awards in our IMS segment including the receipt of multi-year funding awards received on our naval power and propulsion programs to support the CVN 80/81 carriers program ($212 million). Additionally, our ASC segment received production awards for next generation Dismounted Soldier Sensing and Airborne Force Protection programs generating $30 million and $40 million of incremental bookings, respectively. This was offset by the significant TROPHY™ APS award received in 2019 ($195 million) that did not recur in 2020.

------

**Exhibit 99.1**

***Free cash flow***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Free cash flow increased by $44 million, or 59.5%, to $118 million for the year ended December 31, 2021 from $74 million for the year ended December 31, 2020. This was primarily attributable to the increase in net earnings of $69 million realized during the period. The free cash flow contribution from net earnings was partially offset by an increase operating working capital relating to timing and the ongoing transition of development and the related contract asset liquidations.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Free cash flow decreased by $36 million, or 32.7%, to $74 million for the year ended December 31, 2020 from $110 million for the year ended December 31, 2019. This was primarily attributable to increases in operating working capital relating to timing and the ongoing transition of development programs to production.

**Review of Operating Segments**

The following is a discussion of operating results for each of our operating segments. We have elected to use Revenue, Adjusted EBITDA, Adjusted EBITDA Margin, Bookings and Backlog to provide detailed information on our segment performance. Additional information regarding our segments can be found in *[Note 17: Segment information](#i195ed586c79140398faaf3bea4dcb04b_130)* within the Consolidated Financial Statements.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** | **2021 vs. 2020<br>Variance** | **2021 vs. 2020<br>Variance** | **2020 vs. 2019<br>Variance** | **2020 vs. 2019<br>Variance** |
| **(Dollars in millions)** | **2021** | **2020** | **2019** | **2021 vs. 2020<br>Variance** | **2021 vs. 2020<br>Variance** | **2020 vs. 2019<br>Variance** | **2020 vs. 2019<br>Variance** |
| ***Revenue:*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;ASC | $1940 | $1958 | $1810 | $(18) | (0.9)% | $148 | 8.2% |
| &nbsp;&nbsp;&nbsp;IMS | 959 | 834 | 917 | $126 | 15.1% | (84) | (9.1%) |
| &nbsp;&nbsp;&nbsp;Corporate & Eliminations | (20) | (14) | (13) | $(6) | 42.9% | (1) | 7.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenue | $2879 | $2778 | $2714 | $102 | 3.7% | $64 | 2.3% |
| ***Adjusted EBITDA:*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ASC | $220 | $213 | $169 | $7 | 3.3% | $44 | 26.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;IMS | 90 | 55 | 63 | 35 | 63.6% | (8) | (12.7%) |
| &nbsp;&nbsp;&nbsp;Corporate & Eliminations |  |  | 2 |  | (100.0)% | (2) | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Adjusted EBITDA | $310 | $268 | $234 | $42 | 15.7% | $34 | 14.5% |
| ***Adjusted EBITDA Margin:*** | ***Adjusted EBITDA Margin:*** | ***Adjusted EBITDA Margin:*** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;ASC | 11.3% | 10.9% | 9.3% | 0.4% | 4.2% | 1.6% | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;IMS | 9.4% | 6.6% | 6.9% | 2.8% | 42.2% | (0.3%) | (4.3%) |
| ***Bookings:*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;ASC | $1691 | $2019 | $2021 | $(328) | (16.2)% | $(2) | (0.1%) |
| &nbsp;&nbsp;&nbsp;IMS | 904 | 1036 | 902 | (132) | (12.7)% | 134 | 14.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total bookings | $2595 | $3055 | $2923 | $(460) | (15.1)% | $132 | 4.5% |
| ***Backlog:*** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;ASC | $1762 | $2066 | $2070 | $(304) | (14.7)% | $(4) | (0.2)% |
| &nbsp;&nbsp;&nbsp;IMS | 1099 | 1225 | 774 | (126) | (10.3)% | 451 | 58.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total backlog | $2861 | $3291 | $2844 | $(430) | (13.1)% | $447 | 15.7% |

---

------

**Exhibit 99.1**

**Year Ended December 31, 2021 Compared to the Year Ended December 31, 2020 and 2019**

***ASC***

*Revenue:* 

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>*** 

In total, ASC segment revenue decreased $18 million, or (1%), from $1,958 million for the year ended December 31, 2020 to $1,940 million for the year ended December 31, 2021. Though the segment realized revenue growth on the transition from development to production on our recently awarded Next Generation dismounted soldier targeting system ($37 million) and the continuation of providing upgraded vehicle sensing for the Bradley Fighting Vehicle ($16 million), both with the U.S. Army, this growth was offset by a reduction in Second Generation ground vehicle components with the U.S. Army of $18 million, reduced demand of certain computing hardware and antenna programs with the U.S. Navy of $17 million and $15 million, respectively. Additionally, we realized a decline in bandwidth awards on our Global Network programs with various DoD customers reducing revenue by $27 million as compared to the prior year.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

The revenue growth at our ASC segment was driven principally by programs transitioning from development to production and increased deliveries in our next generation dismounted Soldier Sensing and Targeting Systems programs, resulting in $109 million of additional revenue as compared to the prior year. Additionally newly awarded advanced combat networking hardware and ruggedized maintenance support programs contributed $41 million and $29 million of additional revenue, respectively. Our ASC segment also realized annual revenue expansion through progress on our recently awarded electronic control systems program for the U.S. Navy shipboard launch system ($22 million) and Pilot Training ($29 million) programs. This revenue growth was offset in part by lower Airborne Force Protection programs revenue resulting from the transition from our accelerated production efforts under the Urgent Operational Needs ("ONS") program with the U.S. Navy in 2019 to development efforts to expand program capabilities in 2020, reducing revenue by $30 million. Additionally, a management decision to focus on program pursuits that better fit our strategic investment profile, lowered Naval common network services equipment by $64 million and lower throughput on antenna programs with the U.S. Navy of $16 million. In total, segment revenue increased $148 million, or 8.2%, from $1,810 million for the year ended December 31, 2019 to $1,958 million for the year ended December 31, 2020.

*Adjusted EBITDA and Adjusted EBITDA Margin:* 

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

ASC's Adjusted EBITDA increased by $7 million, or 3.3%, from $213 million for the year ended December 31, 2020 to $220 million for the year ended December 31, 2021. The EBITDA growth, contributed to the Adjusted EBITDA Margin increase from 10.9% for the year ended December 31, 2020 to 11.3% for the year ended December 31, 2021. The increase in Adjusted EBITDA is primarily attributed to the revenue increase noted above coupled with performance improvements in our electronic warfare, signal intelligence, computing hardware programs for the U.S. Navy's shipboard launch systems and Bradley Ground vehicle sensing programs. Offsetting the improved program performance and revenue expansion is increased general and administrative costs driven primarily by increased investments in IR&D efforts to support the continued market position of the segment. The increased discretionary expenditures offset the margin expansion realized by improved program performance resulting in a slight increase in Adjusted EBITDA margin of 40 basis points to 11.3%.

------

**Exhibit 99.1**

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

ASC's Adjusted EBITDA increased by $44 million, or 26.0%, from $169 million for the year ended December 31, 2019 to $213 million for the year ended December 31, 2020. Adjusted EBITDA Margin increased from 9.3% for the year ended December 31, 2019 to 10.9% for the year ended December 31, 2020. This increase in Adjusted EBITDA is primarily attributed to the revenue increase noted above coupled with a favorable program mix with revenue growth in our higher margin program areas including pilot training and the reduction in revenue from our lower margin Naval common network services equipment by $64 million. These increases were offset in part by changes in our assumed recovery for certain requests for equitable adjustments in certain electronics programs with the U.S. Navy impacting EBITDA by $11 million. The favorable program mix and revenue growth in excess of general and administrative costs growth contributed to the Adjusted EBITDA margin expansion of 160 basis points to 10.9%.

*Bookings:*

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

ASC's bookings decreased by $328 million, or 16.2%, from $2,019 million for the year ended December 31, 2020 to $1,691 million for the year ended December 31, 2021. The bookings reduction to the prior year is attributed to multi-year production awards realized on our Next Generation of Family of Soldier Sensing Systems and Airborne Missile Warning programs with the U.S. Army which resulted a reduction in bookings of $156 million and $37 million, respectively. Additionally the lower demand of ruggedized computing maintenance support programs with the U.S. Army attributed to the decease over the prior year. Our bookings continue to be highlighted by our foundational programs including follow-on awards received for our ruggedized computing and battle management systems with the U.S. Army ($138M), our Submarine hardware upgrade programs with the U.S. Navy ($100M) and our Global Network program awards with Special Operations Command ("SOCOM") and the U.S. Army ($132 million). The bookings reduction was partially offset by the receipt of a Ground Vehicle Remote Weapon Sight program with the US Army ($57 million) and the Air Force decision to equip the Joint Strike Fighter (JSF) lot 15 with pilot training systems ($37 million).

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

ASC's bookings decreased by $2 million, or 0.1%, from $2,021 million for the year ended December 31, 2019 to $2,019 million for the year ended December 31, 2020. Our bookings are highlighted by the continuance of our foundational programs including follow on Global Network program awards with Special Operations Command ("SOCOM") and the U.S. Army and incremental funding on our MFoCS ruggedized computing hardware programs for $164 million and $180 million, respectively, and the Next Generation Thermal Weapon Sight and Limited Interim Warning System programs, which had significant bookings of $168 million and $74 million, respectively, an increase of $30 million and $67 million, respectively, compared to the prior year ended December 31, 2019. The bookings growth was more than offset by the previously disclosed transition from Airborne Force Protection ONS production awards received in 2019 to development programs resulting in a year over year bookings reduction of $72 million coupled with the strategic decision to focus our efforts and capacity on program pursuits that better fit our strategic investment profile, lowering our exposure to Naval common network services equipment by $37 million.

*Backlog:*

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

ASC's backlog decreased by $304 million, or 14.7%, from $2,066 million for the year ended December 31, 2020 to $1,762 million for the year ended December 31, 2021. This was attributed to anticipated progress on the multi-year production awards received in 2020 for our Next Generation Soldier Sensing program with the U.S. Army.

------

**Exhibit 99.1**

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

ASC's backlog decreased by $4 million, or 0.2%, from $2,070 million for the year ended December 31, 2019 to $2,066 million for the year ended December 31, 2020. This was attributed to revenue slightly outpacing new bookings.

***IMS***

*Revenue:*

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

IMS revenue increased by $126 million, or 15%, from $834 million for the year ended December 31, 2020 to $959 million for the year ended December 31, 2021. The revenue increase was driven by contracted efforts to provide the U.S. Army with Mission Equipment Packages to support mobile short range air defense capabilities ($158 million) and continued progress providing power conversion equipment and electrical components and systems to the U.S. Navy to support the CVN 80/81 carrier ($72 million) and Columbia Class programs ($36 million). The IMS revenue growth was partially offset by the completion of the urgent operational needs TROPHY<sup>TM</sup> APS program ($93 million) which realized significant production efforts in 2020.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

IMS revenue decreased by $83 million, or 9%, from $917 million for the year ended December 31, 2019 to $834 million for the year ended December 31, 2020. This decrease was mostly attributed to the acceleration of $161 million of revenue on the APS program in 2019. Offsetting this decrease is incremental revenue generated from our recently awarded position on the Submarine Power Conversion program of $14 million and the receipt of our full rate production award for CUAS programs with the U.S. Army generating incremental $28 million of revenue as compared to 2019.

*Adjusted EBITDA and Adjusted EBITDA Margin:*

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

In total, IMS's Adjusted EBITDA increased by $35 million, or 63.6%, from $55 million for the year ended December 31, 2020 to $90 million for the year ended December 31, 2021. Adjusted Margin increased 280 bps from 6.6% for the year end December 31, 2020 to 9.4% for the year ended December 31, 2021. This increase in Adjusted EBITDA and margin improvement was attributed to the revenue expansion coupled with improved program performance on fixed price development program efforts including submarine power and propulsion system components for the U.S. Navy's Columbia Class Program which realized losses of $37 million in the period ended December 31, 2020 as compared to $3 million during the current year.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

IMS's Adjusted EBITDA decreased by $8 million, or 12.2%, from $63 million for the year ended December 31, 2019 to $55 million for the year ended December 31, 2020. Adjusted Margin decreased from 6.9% for the year end December 31, 2019 to 6.6% for the year ended December 31, 2020. This decrease in Adjusted EBITDA and margin reduction was attributed to cost growth on fixed price development program efforts including submarine power and propulsion system components for the U.S. Navy impacting EBITDA margins by $37 million.

------

**Exhibit 99.1**

*Bookings:*

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Bookings as of December 31, 2021 were $904 million highlighted by the receipt of awards totaling $250 million for mission equipment packages for counter unmanned short range air defense and $140 million for electrical propulsion components for production efforts on the Columbia Class Program. The bookings decreased $(132) million, or 12.7%, from $1,036 million as of December 31, 2020 driven primarily to the prior year multi-year awards received in the prior year to support the CVN 80/81 carriers driving a reduction in annual bookings of $210 million.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Bookings increased by $134 million, or 14.9%, from $902 million as of December 31, 2019 to $1,036 million as of December 31, 2020. This increase was driven by awards received to support the CVN 80/81 carriers generating incremental bookings of $212 million as compared to the prior year. Further, our CUAS programs generated $19 million of additional awards as those programs transitioned from development into full rate production. These increases were largely offset by a reduction of awards received on our TROPHY™ APS programs of $195 million.

*Backlog:*

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Backlog decreased by $(126) million, or (10.3%), to $1,099 million for the year ended December 31, 2021 from $1,225 million for the year ended December 31, 2020. The backlog reduction is due primarily to progress on our awards to support the CVN 80/81 program ($85 million).

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Backlog increased by $451 million, or 58.3%, to $1,225 million for the year ended December 31, 2020 from $774 million for the year ended December 31, 2019. This was due to strong bookings driven principally by our awards to support the CVN 80/81 program ($212 million) and increased unfunded backlog on our submarine power and propulsion system components and other hybrid drive programs by $101 million.

**Quarterly Results**

The following table sets forth selected unaudited quarterly results of operations data for each of the eight quarters in the period ended December 31, 2021. This data should be read in conjunction with our audited Consolidated Financial Statements and related notes included elsewhere in this document. These quarterly operating results are not necessarily indicative of our operating results for a full year or any future period.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2021** | **2021** | **2021** | **2021** | **2020** | **2020** | **2020** | **2020** |
| (Dollars in millions, except per share amounts) | **Q4** | **Q3** | **Q2** | **Q1** | **Q4** | **Q3** | **Q2** | **Q1** |
| Total revenues | $820 | $720 | $658 | $681 | $826 | $719 | $650 | $583 |
| Interest expense | 8 | 9 | 9 | 9 | 15 | 17 | 17 | 15 |
| Net earnings | 58 | 35 | 32 | 29 | 47 | 15 | 13 | 10 |
| Adjusted EBITDA<sup>(1)</sup> | 100 | 70 | 69 | 71 | 117 | 56 | 45 | 50 |
| Free cash flow<sup>(1)</sup> | 271 | 61 | 48 | (262) | 339 | 1 | 43 | (309) |

---

------

**Exhibit 99.1**

_______________

(1)See Part II. Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations—Key Financial and Operating Measures—Non-GAAP Financial Measures" above for definitions of these measures. Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EPS, Leverage Ratio and free cash flow are non-GAAP measures. See Part II. Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations—Key Financial and Operating Measures—Non-GAAP Financial Measures" above for reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.

------

**Exhibit 99.1**

**Liquidity and Capital Resources**

We endeavor to ensure the most efficient conversion of operating income into cash for deployment in our business and to maximize shareholder value through cash deployment activities. In addition to our cash position, we use various financial measures to assist in capital deployment decision-making, including cash provided by operating activities and free cash flow, a non-GAAP measure described in more detail below. We believe that the combination of our existing cash, access to credit facilities as described in *[Note 11: Debt](#i195ed586c79140398faaf3bea4dcb04b_112)* and future cash that we expect to generate from our operations will be sufficient to meet our short and long-term liquidity needs. There can be no assurance, however, that our business will continue to generate cash flow at current levels or that anticipated operational improvements will be achieved. We may also pursue acquisitions or other strategic priorities that will require additional liquidity beyond the liquidity we generate through our operations. Our cash balance as of December 31, 2021 was $240 million compared to $61 million as of December 31, 2020.

The following table summarizes our cash flows for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| (Dollars in millions) | **2021** | **2020** | **2019** |
| Net cash provided by operating activities | $178 | $125 | $157 |
| Net cash provided by (used in) investing activities | 39 | (70) | (151) |
| Net cash used in financing activities | (38) | (80) | (1) |
| Effect of exchange rate changes on cash and cash equivalents |  | 1 | 1 |
| Net increase (decrease) in cash and cash equivalents | $179 | $(24) | $6 |
| Free cash flow<sup>(1)</sup> | $118 | $74 | $110 |

---

________________

(1)Free cash flow is a Non-GAAP measure. The reasons we use this Non-GAAP financial measure and its reconciliation to the most directly comparable U.S. GAAP financial measure is provided above under "Part II. Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Key Financial and Operating Measures—Non-GAAP Financial Measures."

**Year Ended December 31, 2021 Compared to the Years Ended December 31, 2020 and 2019**

***Operating Activities***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

We generated cash from operating activities of $178 million for the year ended December 31, 2021 as compared to $125 million for the year ended December 31, 2020. This increase was primarily attributed to increased Net Income driven by our improved profitability and reduction in interest related expenditures which was offset in part by an increase in working capital during the period. In total our changes in our assets and liabilities absorbed $65 million of cash for the year ended December 31, 2021 compared to $46 million for the year ended December 31, 2020. The growth in net assets is primarily attributed to investments in Contract Assets as of December 31, 2021 which resulted in a $71 million use of cash during the period. Additionally, we also generated higher accounts receivables driving a cash usage of $54 million. This increase in working capital was partially offset by a $42 million reduction in our inventory levels attributed to progress on certain sensor programs within our ASC segment.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

We generated cash from operating activities of $125 million for the year ended December 31, 2020 as compared to $157 million for the year ended December 31, 2019. This decrease was primarily attributed to an increase in working capital resulting from a reduction in our vendor payable

------

**Exhibit 99.1**

obligations in December 31, 2020 as compared to the prior year. This resulted in cash usage of $58 million. Additionally, we also generated higher accounts receivables driving a cash usage of $35 million. This increase in working capital was partially offset by a $65 million reduction in contract assets in connection with the achievement of billable milestones on development type programs, including our APS program, which reduced contract assets by $60 million during the year. In addition to the contract asset reduction, we also decreased working capital through the social security payroll tax deferral offered as part of the COVID-19 relief efforts.

***Investing Activities***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investing activities generated $39 million of cash during the year ended December 31, 2021 as compared to $70 million usage during the year ended December 31, 2020. The $109 million improvement in investing cash inflows is attributed to the 2020 loan of $115 million issued to US Holding. The loan was repaid during the 2021 fiscal year and a subsequent loan was not issued in December 2021. In addition during the year ended December 31, 2021 we completed an acquisition for $11 million offsetting the increase from our other investing activities. See *Note 1. Summary of Significant Accounting Policies f*or further detail on the Ascendant Engineering Solutions (AES) acquisition.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Investing activities used $70 million of cash during the year ended December 31, 2020 as compared to $151 million during the year ended December 31, 2019. The $81 million reduction in investing cash outflows is attributed to the 2019 loan of $100 million issued to US Holding. The loan was repaid during the 2020 fiscal year and a subsequent loan was issued totaling $115 million in December of 2020. The net cash outflow of the intercompany loans was $15 million in 2020 compared to $100 million in 2019.

***Financing Activities***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Cash used in financing activities for the year ended December 31, 2021 and December 31, 2020 was $38 million and $80 million, respectively. Cash used in financing activities consisted of the $20 million payment of our 5.0% Daylight term loan and the repayment of other short term debt obligations of $12 million.

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Cash used in financing activities for the year ended December 31, 2020 and December 31, 2019 was $80 million and $1 million, respectively. Cash used in financing activities increased primarily as a result of the principal payment of our 4% term debt of $50 million and $15 million of principal reduction of the Daylight Term Loan.

***Free Cash Flow***

***<u>Year Ended December 31, 2021 Compared With Year Ended December 31, 2020</u>***

Free cash flow increased by $44 million, or 59.5%, to $118 million for the year ended December 31, 2021 as compared to $74 million for the year ended December 31, 2020. This was primarily due to growth in net income and a reduction in Inventory of $42 million. This was partially offset by investments in our net asset position. See cash flows from operations for further detail.

------

**Exhibit 99.1**

***<u>Year Ended December 31, 2020 Compared With Year Ended December 31, 2019</u>***

Free cash flow decreased by $36 million, or 32.7%, to $74 million for the year ended December 31, 2020 as compared to $110 million for the year ended December 31, 2019. This was primarily due to growth in operating working capital driven from a reduction in accounts payable of $58 million and accounts receivable growth of $35 million year over year. This was largely offset by reduction in contract assets of $65 million as we completed development programs and transitioned them to production programs.

------

**Exhibit 99.1**

**Material Cash Requirements**

As of December 31, 2021, our material cash requirements were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** |
| (Dollars in millions) | **Total** | **Less than<br>1 Year** | **1-3<br>Years** | **3-5<br>Years** | **More than<br>5 Years** |
| Borrowings with related parties<sup>(1)</sup> | $246 | $34 | $212 | $— | $— |
| Loans from banks | 15 | 15 |  |  |  |
| Operating leases | 106 | 27 | 44 | 21 | 14 |
| Finance leases and other<sup>(2)</sup> | 246 | 15 | 30 | 28 | 173 |
| Post-retirement obligations<sup>(3)</sup> | 137 | 13 | 27 | 28 | 69 |
| Purchase commitments<sup>(4)</sup> | 815 | 683 | 98 | 13 | 21 |
| Total | $1565 | $787 | $411 | $90 | $277 |

---

________________

(1)Includes scheduled interest payments.

(2)Finance leases and other includes a build-to-suit, failed sale leaseback asset obligation of $48 million as of December 31, 2021. See *Note 11: Debt of our Notes to Consolidated Financial Statements*.

(3)Post-retirement obligations include those amounts we expect to pay out in benefits payments and are further explained in Note 12: *Pension and Other Postretirement Benefit*s of our Notes to Consolidated Financial Statements.

(4)Purchase commitments include open purchase orders with vendors for which the Company is contractually obligated.

***Off-Balance Sheet Arrangements***

As of December 31, 2021 and 2020, we had no significant off balance sheet arrangements.

**Critical Accounting Policies and Estimates**

The following is not intended to be a comprehensive list of all of our accounting policies. Our significant accounting policies are more fully described in *Note 1: Summary of Significant Accounting Policies* to the Consolidated Financial Statements. In many cases, the accounting treatment of a particular transaction is dictated by accounting principles generally accepted in the United States of America. Other areas require management's judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and costs and expenses during the reporting period. Ultimately, actual amounts may differ from these estimates. We believe that critical accounting estimates have the following attributes: (1) they require management to make assumptions about matters that are uncertain at the time of the estimate; and (2) different estimates we reasonably could have used, or changes in the estimates that are reasonably likely to occur, that would have a material effect on our consolidated financial condition or results of operations.

We believe the following critical accounting policies contain the more significant judgments and estimates used in the preparation of our Consolidated Financial Statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue Recognition and Contract Estimates

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reviews for Impairment of Goodwill and Long-Lived Assets

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pension Assumptions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income Taxes

------

**Exhibit 99.1**

***Revenue Recognition on Contracts and Contract Estimates***

We recognize revenue from contracts with customers using the five-step model prescribed in ASC 606. Substantially all of our contracts are accounted for using the over time, cost-to-cost accounting method as determined by the ratio of cumulative costs incurred to date to estimated total contract costs at completion. We believe this is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of our work and transfer of control to our customers.

Revenue and cost estimates for substantially all over time contract performance obligations are reviewed and updated quarterly. Contract estimates are based on various assumptions to project the outcome of future events that can span multiple years. These assumptions include labor productivity and availability, the complexity of the work to be performed, the cost and availability of materials, the performance of subcontractors and the availability and timing of funding from the customer. Changes in estimates affecting sales, costs and profits are recognized in the period in which the change becomes known using the cumulative catch-up method. Under this method, the impact of the adjustment on profit recorded to date on a contract is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance are recognized using the adjusted estimate. The aggregate impact of adjustments in contract estimates are $34 million, $77 million, and $55 million for 2021, 2020, and 2019, respectively. The changes in estimates are primarily attributed to changes in our firm-fixed-priced development type programs. As changes happen in the design to meet required specifications, those changes often result in changes to the overall profitability of the programs. Our contract reviews are conducted at least quarterly in which we incorporate our best estimate to complete the program known at that point in time.

For further discussion, see *Note 2*: *Revenue from Contracts with Customers* to the Consolidated Financial Statements.

***Reviews for Impairment of Goodwill and Long-lived Assets***

Goodwill represents the excess purchase price paid to acquire a business over the fair value of net assets acquired. We review goodwill for impairment annually at each of our reporting units or when changes in circumstances indicate that the carrying value may not be recoverable. Such circumstances include a significant adverse change in the business climate for one of our reporting units or a decision to dispose of a reporting unit or a significant portion of a reporting unit.

We use both qualitative and quantitative approaches when testing goodwill for impairment. When determining the approach to be used, we consider the current facts and circumstances of each reporting unit as well as the excess of each reporting unit's estimated fair value over its carrying value based on our most recent quantitative assessments. Our qualitative approach evaluates the business environment and various events impacting the reporting unit including, but not limited to, macroeconomic conditions (e.g., impact of COVID-19), changes in the business environment and reporting unit-specific events. If, based on the qualitative assessment, we determine that it is more likely than not that the fair value of a reporting unit is greater than its carrying value, then a quantitative assessment is not necessary. However, if a quantitative assessment is determined to be necessary, we estimate the fair value of the reporting unit and compare that to its carrying value. To the extent the carrying value exceeds the fair value of a reporting unit, an impairment is recorded for the amount equal to this excess.

Our estimate of fair value is based primarily on the discounted projected cash flows of the underlying operations and requires the use of judgment by management. The process requires numerous assumptions, including the timing of work embedded in our backlog, our performance and profitability under our contracts, our success in securing future business and the appropriate risk adjusted interest rate used to discount the projected cash flows. Due to the variables inherent in our estimates of fair value, differences in assumptions may have a material effect on the result of our impairment analysis.

------

**Exhibit 99.1**

As of December 31, 2021 and 2020, we completed qualitative assessments for our reporting units that did not identify the need for further analysis. As a result, no impairments to goodwill were recorded.

Long-lived assets held for use, which primarily includes finite-lived intangible assets and property, plant and equipment, are evaluated for impairment whenever events or circumstances indicate that the undiscounted net cash flows to be generated by their use over their expected useful lives and eventual disposition are less than their carrying value. The long-term nature of these assets requires the estimation of their cash inflows and outflows several years into the future and only takes into consideration technological advances known at the time of the impairment test.

***Pension Assumptions***

Our defined-benefit pension and other post-retirement benefit costs and obligations depend on several assumptions and estimates. The key assumptions include interest rates used to discount estimated future liabilities and projected long-term rates of return on plan assets. The expected long-term rate of return is based on the market expectations at the beginning of the period for returns over the entire life of the related obligation. These retirement plan assumptions are based on our best judgment, including consideration of current and future market conditions. In the event any of the assumptions change, pension and other post-retirement benefit cost could increase or decrease. For further discussion about our retirement plan assumptions, see *: Note 12. Pension and Other Postretirement Benefits* to the Consolidated Financial Statements.

***Income Taxes***

We account for income taxes under the asset and liability method in accordance with the accounting standard for income taxes. The asset and liability method requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities. Under this method, changes in tax rates and laws are recognized in income in the period such changes are enacted.

We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent results of operations. If we were to determine that we would be able to realize our deferred income tax assets in the future in excess of their net recorded amount or would no longer be able to realize our deferred income tax assets in the future as currently recorded, we would make an adjustment to the valuation allowance which would decrease or increase the provision for income taxes.

The provision for federal, state, foreign and local income taxes is calculated on income before income taxes based on current tax law and includes the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Such provision differs from the amounts currently payable because certain items of income and expense are recognized in different reporting periods for financial reporting purposes than for income tax purposes.

We recognize liabilities for uncertain tax positions when it is more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions are measured based upon the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. We recognize interest and penalties related to uncertain tax positions in our income tax expense.

As of December 31, 2021 and December 31, 2020, we had gross deferred tax assets of $120 million and $154 million, respectively, and deferred tax asset valuation allowances of $10 million and $11 million, respectively. The deferred tax assets principally relate to benefit accruals, inventory obsolescence, tax benefit carryforwards and contract reserves. The deferred tax assets as of December 31, 2021 and

------

**Exhibit 99.1**

December 31, 2020 include $21 million and $39 million, respectively, related to tax benefit carryforwards associated with net operating losses.

***Accounting Standards Updates (ASU)***

See *[Note 1: Summary of Significant Accounting Policies](#i195ed586c79140398faaf3bea4dcb04b_82)* to the Consolidated Financial Statements for information regarding accounting standards we adopted in 2021 and other new accounting standards that have been issued by the Financial Accounting Standards Board but are not effective until after December 31, 2021.

------

**ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA**

------

**Report of Independent Registered Public Accounting Firm**

To the Shareholder and Board of Directors

Leonardo DRS, Inc.:

*Opinion on the Consolidated Financial Statements*

We have audited the accompanying consolidated balance sheets of Leonardo DRS, Inc. and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, shareholder's equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.

*Basis for Opinion*

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

*Critical Audit Matter*

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

*Estimation of costs to complete for certain long-term contracts*

As discussed in Notes 1(D) and 2 to the consolidated financial statements, the Company recognizes revenues for the majority of contracts determined using the ratio of cumulative costs incurred to date to estimated total contract costs at completion. The accounting for long-term contracts involves estimation of the costs to complete a contract in order to accurately recognize the associated revenues. Developing the estimated total contract costs to complete a contract

------

often requires judgment related to the nature and complexity of the work to be performed, subcontractor performance and the risk and impact of delayed performance.

We identified the assessment of the estimation of costs to complete for certain long-term contracts in the Integrated Mission Systems segment as a critical audit matter. The evaluation of the costs to complete for certain contracts required a high level of subjective auditor judgment, due to the nature and complexity of the work to be performed for these contracts, subcontractor performance and the risk and impact of delayed performance. Changes to the estimated costs to complete each contract could have a significant impact on the estimated revenues recorded during the period.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design of certain internal controls related to the estimation of costs to complete the selected long-term contracts. For certain contracts, we compared the Company's historical estimates of costs to actual costs incurred to assess the Company's ability to estimate accurately. Based on the nature of the individual contract, we evaluated the Company's estimated costs to complete by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• reading the underlying contract and related amendments to obtain an understanding of the contractual requirements and related performance obligations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• assessing costs incurred to-date compared to estimated total contract costs at completion and the relative progress toward satisfying the performance obligation(s) of the contract

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• assessing, if relevant, the estimated costs to complete on similar or predecessor contracts and programs

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• inquiring of financial and operational personnel of the Company to identify factors that should be considered within the estimated cost to complete or indications of potential management bias

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• inspecting correspondence, if any, between the Company and the customer regarding actual to-date and expected performance

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• analyzing the sufficiency of the Company's assessment of contract performance risks included within the estimated costs to complete.

/s/ KPMG LLP

We served as the Company's auditor from 2012 to 2022.

McLean, Virginia

March 28, 2022, except for notes 1A, 1T, 2, 7, 13, 15, and 17, as to which the date is August 2, 2022, and notes 1Q and 18, as to which the date is March 27, 2023

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**Consolidated Statements of Earnings** 

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| (Dollars in millions, except per share amounts) | **2021** | **2020** | **2019** |
| Revenues: |  |  |  |
| Products | $2505 | $2412 | $2220 |
| Services | 374 | 366 | 494 |
| **Total revenues** | 2879 | 2778 | 2714 |
| Cost of revenues: |  |  |  |
| Products | (2067) | (2000) | (1904) |
| Services | (265) | (284) | (351) |
| **Total cost of revenues** | (2332) | (2284) | (2255) |
| Gross profit  | 547 | 494 | 459 |
| General and administrative expenses | (293) | (283) | (277) |
| Amortization of intangibles | (9) | (9) | (9) |
| Other operating expenses, net | (9) | (21) | (10) |
| **Operating earnings**  | 236 | 181 | 163 |
| Interest expense | (35) | (64) | (65) |
| Other, net | (1) | (5) | (3) |
| **Earnings before taxes**  | 200 | 112 | 95 |
| Income tax provision | 46 | 27 | 20 |
| **Net earnings**  | $154 | $85 | $75 |
| Net earnings per share from common stock: |  |  |  |
| Basic and diluted earnings per share: | 0.73 | $0.40 | $0.36 |

---

See accompanying Notes to Consolidated Financial Statements.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**Consolidated Statements of Comprehensive Income** 

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| (Dollars in millions) | **2021** | **2020** | **2019** |
| **Net earnings**  | $154 | $85 | $75 |
| Other comprehensive income (loss): |  |  |  |
| Foreign currency translation (loss) gain, net of income taxes | 2 | 1 | 3 |
| Net unrecognized gain (loss) on postretirement obligations, net of income taxes | 10 | 22 | (15) |
| **Other comprehensive income (loss), net of income tax**  | 12 | 23 | (12) |
| **Total comprehensive income**  | $166 | $108 | $63 |

---

See accompanying Notes to Consolidated Financial Statements.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| (Dollars in millions, except per share amounts) | **2021** | **2020** |
| **ASSETS** |  |  |
| *Current assets:* |  |  |
| Cash and cash equivalents | $240 | $61 |
| Accounts receivable, net | 156 | 102 |
| Contract assets | 743 | 672 |
| Inventories | 205 | 247 |
| Related party note receivable |  | 115 |
| Prepaid expenses | 23 | 33 |
| Other current assets | 22 | 33 |
| Total current assets | 1389 | 1263 |
| *Noncurrent assets:* |  |  |
| Property plant and equipment, net | 364 | 355 |
| Intangible assets, net | 52 | 60 |
| Goodwill | 1071 | 1057 |
| Deferred tax assets | 56 | 87 |
| Other noncurrent assets | 137 | 134 |
| Total noncurrent assets | 1680 | 1693 |
| **Total assets**  | $3069 | $2956 |
| **LIABILITIES AND SHAREHOLDER'S EQUITY** |  |  |
| *Current liabilities:* |  |  |
| Short-term borrowings and current portion of long-term debt | $41 | $53 |
| Accounts payable | 479 | 478 |
| Contract liabilities | 174 | 177 |
| Other current liabilities | 295 | 267 |
| Total current liabilities | 989 | 975 |
| *Noncurrent liabilities:* |  |  |
| Long-term debt | 352 | 374 |
| Pension and other postretirement benefit plan liabilities | 61 | 88 |
| Other noncurrent liabilities | 74 | 92 |
| Total noncurrent liabilities | $487 | 554 |
| *Shareholder's equity:* |  |  |
| Preferred stock, $0.01 par value: 10,000,000 shares authorized; none issued | $— | $— |
| Common stock, $0.01 par value: 350,000,000 shares authorized; 210,445,073 shares issued and outstanding | 2 | 2 |
| Additional paid-in capital | 4632 | 4632 |
| Accumulated deficit | (2983) | (3137) |
| Accumulated other comprehensive loss | (58) | (70) |
| **Total shareholder's equity**  | 1593 | 1427 |
| **Total liabilities and shareholder's equity**  | $3069 | $2956 |

---

See accompanying Notes to Consolidated Financial Statements.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**Consolidated Statements of Cash Flows**

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| (Dollars in millions) | **2021** | **2020** | **2019** |
| **Operating activities** |  |  |  |
| Net earnings | $154 | $85 | $75 |
| Adjustments to reconcile net earnings (loss) to net cash from operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 58 | 53 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 31 | 30 | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  | 3 | 3 |
| Changes in assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (54) | (35) | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | (71) | 65 | (166) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 42 | (38) | (36) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 10 | (14) | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 12 | 3 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent assets | 19 | 22 | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;Defined benefit obligations | (13) | (9) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 28 | 30 | (11) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent liabilities | (36) | (14) | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 1 | (58) | 156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | (3) | 2 | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 178 | 125 | 157 |
| **Investing activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (60) | (56) | (55) |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisitions, net of cash acquired | (14) |  | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of assets |  | 5 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net repayments received (advances) on related party note receivable | 115 | (15) | (100) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost method investment | (2) | (4) |  |
| Net cash provided by (used in) investing activities | 39 | (70) | (151) |
| **Financing activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (decrease) increase in third party borrowings (maturities of 90 days or less) | (18) | (11) | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment of related party debt | (950) | (1170) | (895) |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowings from related parties | 930 | 1105 | 880 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  | (4) | (2) |
| Net cash used in financing activities | (38) | (80) | (1) |
| Effect of exchange rate changes on cash and cash equivalents |  | 1 | 1 |
| Net increase (decrease) in cash and cash equivalents | 179 | (24) | 6 |
| Cash and cash equivalents at beginning of year | 61 | 85 | 79 |
| Cash and cash equivalents at end of year | $240 | $61 | $85 |
| **Supplemental disclosure of non-cash investing and financing activities** |  |  |  |
| Forgiveness of related party debt | $— | $300 | $— |
| Additions of property plant and equipment and long-term debt for a build-to-suit lease | $— | $49 | $— |

---

See accompanying Notes to Consolidated Financial Statements.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**Consolidated Statements of Shareholder's Equity**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| (Dollars in millions, except per share amounts) | **Common stock** | **Additional paid- in capital** | **Accumulated other comprehensive loss** | **Accumulated deficit** | **Total** |
| **Balance as of December 31, 2018**  | $2 | $4332 | $(81) | $(3297) | $956 |
| Total comprehensive income (loss) |  |  | (12) | 75 | 63 |
| **Balance as of December 31, 2019**  | 2 | 4332 | (93) | (3222) | 1019 |
| Forgiveness of related party debt |  | 300 |  |  | 300 |
| Total comprehensive income |  |  | 23 | 85 | 108 |
| **Balance as of December 31, 2020**  | 2 | 4632 | (70) | (3137) | 1427 |
| Total comprehensive income |  |  | 12 | 154 | 166 |
| **Balance as of December 31, 2021**  | $2 | $4632 | $(58) | $(2983) | $1593 |

---

See accompanying Notes to Consolidated Financial Statements.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS** 

&nbsp;&nbsp;&nbsp;&nbsp;**Note 1. Summary of Significant Accounting Policies**

**A.Organization**

Leonardo DRS, Inc., together with its wholly owned subsidiaries (hereinafter, "DRS," "the Company," "us," "our," or "we") is a supplier of defense electronics products, systems and military support services. The Company is controlled by Leonardo S.p.A (hereinafter, "Leonardo S.p.A.," "the Parent"), an Italian multi-national aerospace, defense and security company headquartered in Rome, Italy, through its direct sole ownership of Leonardo US Holding, Inc. ("US Holding"). US Holding is the direct and sole shareholder of the Company.

DRS is a provider of defense products and technologies that are used across land, air, sea, space and cyber domains. Our diverse array of defense systems and solutions are offered to all branches of the U.S. military, major aerospace and defense prime contractors, government intelligence agencies, international military customers and industrial markets for deployment on a wide range of military platforms. We focus our capabilities in areas of critical importance to the U.S. military, such as sensing, electronic warfare ("EW"), network computing and communications, force protection and electrical power conversion and propulsion.

&nbsp;&nbsp;&nbsp;&nbsp;These capabilities directly align with our two reportable segments: Advanced Sensing and Computing and Integrated Mission Systems. The U.S. Department of Defense ("DoD") is our largest customer and accounts for approximately 86% and 84% of our total revenues as an end-user for the years ended December 31, 2021 and 2020, respectively. Specific international and commercial market opportunities exist within these segments and comprise approximately 14% and 16% of our total revenues for the years ended December 31, 2021 and 2020. Our two reportable segments reflect the way performance is assessed and resources are allocated by our Chief Executive Officer, who is our chief operating decision maker ("CODM").

*Advanced Sensing and Computing ("ASC")*

The ASC segment provides sensing and computing systems and subsystem solutions to the U.S. military and allied nations focused on solving the most complex threat dynamics facing our service men and women today. We provide world class sensing products in all warfighting domains along with the computation systems to provide situational understanding.

Our technologies and products are deployed on nearly all military platforms across land, sea, air, cyberspace, and space on individual soldiers, ground vehicles, ships, aircraft, and satellites. We have market leading capabilities in electro-optic and infrared imaging, advanced lasers, electronic warfare and cyber, communications, and computing in these domains.

*Integrated Mission Systems ("IMS")* 

The IMS segment provides critical force protection, platform integration, transportation and logistics and power conversion and propulsion systems to the U.S. military and its allies. Our force protection systems provide much needed protection for our service members and military assets from evolving and proliferating threats and include advanced solutions for counter-unmanned aerial systems, short-range air defense systems and active protection systems on ground vehicles. Additionally, we provide power

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

conversion and propulsion systems for the U.S. Navy's top priority shipbuilding programs, building on our legacy of providing power components and systems for nearly all naval combat vessels for three decades, positioning us to continue as a leading provider of electrical ship propulsion systems and components for the U.S. Navy and its allies.

*Other*

The Company separately presents the unallocable costs associated with corporate functions and certain non-operating subsidiaries of the Company as Corporate & Eliminations.

See *Note 17*: *Segment Information* for further information regarding our business segments.

**B.Basis of presentation**

The accompanying Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include the accounts of DRS, its wholly owned subsidiaries and its controlling interests. Interests in joint ventures that are controlled by the Company, or for which the Company is otherwise deemed to be the primary beneficiary, are consolidated. For joint ventures in which the Company does not have a controlling interest, but exerts significant influence, the Company applies the equity method of accounting. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts have been reclassified to conform to current year presentation.

**C.Use of estimates**

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant of these estimates and assumptions relate to the recognition of contract revenues and estimated costs to complete contracts in process, recoverability of reported amounts of goodwill, long-lived assets and intangible assets, valuation of pensions and other postretirement benefits, the valuation of deferred tax assets and liabilities and the valuation of unrecognized tax benefits. Actual results could differ from these estimates.

**D.Revenue Recognition**

Our revenues consist of sales of products (tangible goods) and sales of services to customers. We recognize the majority of our revenue from contracts with customers using an over time, cost-to-cost method of accounting. On certain other contracts, primarily time and material ("T&M") and cost-plus contracts, revenue is recognized using the right-to-invoice practical expedient as we are contractually able to bill our customer based on control transferred to the customer. See *Note 2*: *Revenue from Contracts with Customers* for additional information regarding revenue recognition.

**E.Cost of Revenues**

Cost of revenues includes materials, labor and overhead costs incurred in the manufacturing, design, and provision of products and services sold in the period as well as warranty costs. Material costs include raw materials, purchased components and sub-assemblies, outside processing and inbound freight costs. Labor and overhead costs consist of direct and indirect manufacturing costs, including wages and fringe benefits, operating supplies, depreciation and amortization, occupancy costs, and purchasing, receiving and inspection costs.

**F.Research and Development Expenses**

We conduct research and development ("R&D") activities using our own funds (referred to as company-funded R&D or independent research and development ("IR&D")) and under contractual arrangements with our customers (referred to as customer-funded R&D) to enhance existing products

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

and services and to develop future technologies. R&D costs include basic research, applied research, concept formulation studies, design, development, and related test activities. IR&D costs are allocated to customer contracts as part of the general and administrative overhead costs and generally recoverable on our customer contracts with the U.S. Government. Customer-funded R&D costs are charged directly to the related customer contract. Substantially all R&D costs are charged to cost of revenues as incurred. Company-funded R&D costs charged to cost of revenues totaled $48 million, $41 million and $31 million in 2021, 2020 and 2019, respectively.

**G.Foreign Currency**

Significant transactions in foreign currencies are translated into U.S. dollars at the approximate prevailing rate at the time of the transaction. Foreign exchange transaction gains and losses in 2021, 2020 and 2019 were immaterial to the Company's results of operations. The operations of the Company's foreign subsidiaries are translated from the local (functional) currencies into U.S. dollars using weighted average rates of exchange during each monthly period. The rates of exchange at each balance sheet date are used for translating certain balance sheet accounts and gains or losses resulting from these translation adjustments are included in the accompanying Consolidated Balance Sheet as a component of other comprehensive income.

**H.Cash and Cash Equivalents**

Cash and cash equivalents include cash on hand, deposits with banks or other short-term, highly liquid investments with original maturities of three months or less.

**I.Accounts Receivable**

Accounts receivable consist of amounts billed and currently due from customers. When events or conditions indicate that amounts outstanding from customers may become uncollectible, an allowance is estimated and recorded. See *Note 3*: *Accounts Receivable* for additional information regarding accounts receivable.

**J.Inventories**

Inventories are recorded at the lower of cost (determined by either actual, weighted average or first-in, first-out methods) or net realizable value, and include direct production costs as well as indirect costs, such as factory overhead. The net realizable value is calculated as the expected sales price in the course of normal operations net of estimated costs to finish and sell the goods. See *Note 4*: *Inventories* for additional information regarding inventories.

**K.Property, Plant and Equipment**

Property, plant and equipment is carried at cost less accumulated depreciation. Depreciation is calculated on the straight-line method. The estimated useful lives of plant, machinery and equipment and building and building improvements generally range from 3 to 10 years and 15 to 40 years, respectively. Leasehold improvements are amortized over the shorter of the estimated useful life of the improvements or the remaining life of the lease.

When assets are retired or otherwise disposed of, the cost and related accumulated depreciation or amortization are removed from the Consolidated Balance Sheet, and the net gain or loss is included in the determination of net earnings. Maintenance and repairs are charged to operations as incurred and renewals and improvements are capitalized. See *Note 5*: *Property, Plant and Equipment* for additional information regarding property, plant and equipment.

**L.Goodwill**

Goodwill represents the excess purchase price paid to acquire a business over the fair value of net assets acquired. Goodwill is assigned to reporting units and is reviewed for impairment at the reporting

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

unit level on an annual basis, or whenever changes in circumstances indicate that the carrying amount may not be recoverable. A reporting unit is an operating segment, or one level below that operating segment (the component level) if discrete financial information is prepared and regularly reviewed by the segment manager. Two or more components of an operating segment may be aggregated and deemed a single reporting unit if the components have similar economic characteristics. Based upon the aggregation criteria the Company concluded it had seven reporting units at both December 31, 2021 and 2020.

The annual impairment test is typically performed after completion of the Company's annual financial operating plan, which occurs as of December 31. The Company uses quantitative assessments and qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the optional qualitative assessment is performed (Step 0) and the Company concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, an additional quantitative fair value test (Step 1) is performed. When performing the Step 1 goodwill impairment test, we compare the fair values of each of our reporting units to their respective carrying values. In order to compute the fair value of our reporting units, we primarily use the income approach based on the discounted cash flows that each reporting unit expects to generate in the future, consistent with our operating plans. Determining the fair value of our reporting units requires significant judgments, including the timing and amount of future cash flows, long-term growth rates, determination of the weighted-average cost of capital and terminal value assumptions. If, based on the quantitative fair value test, the Company concludes that the carrying value of the reporting unit exceeds its fair value, the Company will recognize a goodwill impairment loss in an amount equal to that excess. The Company completed impairment tests as of December 31, 2021, 2020 and 2019 and no adjustment to the carrying value of goodwill was deemed to be necessary. See *Note 7*: *Goodwill* for additional information regarding goodwill.

**M.Long-Lived Assets and Acquired Identifiable Intangible Assets**

Identifiable intangible assets represent assets acquired as part of the Company's business acquisitions and include customer and program/contract-related assets. The values assigned to acquired identifiable intangible assets are determined as of the date of acquisition based on estimates and judgments regarding expectations for the estimated future after-tax cash flows from those assets over their lives, including the probability of expected future contract renewals and revenues, all of which are discounted to present value.

The Company assesses the recoverability of the carrying value of its long-lived assets and intangible assets with finite useful lives whenever events or changes in circumstances indicate that the carrying amount of the assets or asset group may not be recoverable. If there are any indicators of impairment present, the Company then evaluates the recoverability of the potentially impaired long-lived assets and acquired identifiable intangible assets based upon expectations of undiscounted net cash flows from such assets. If the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset or asset group, a loss is recognized for the difference between the estimated fair value and the carrying amount of the assets. Assets to be disposed of, including those of discontinued operations, are reported at the lower of the carrying amount or fair value, less the costs to sell. See *Note 5*: *Property, Plant and Equipment* and *Note 8*: *Intangible Assets* for additional information regarding long-lived assets and intangible assets.

**N.Derivative Financial Instruments**

The Company does not use derivative financial instruments for trading purposes. All derivative instruments are carried on the Consolidated Balance Sheet as either assets or liabilities at fair value. The classification of gains and losses resulting from changes in the fair values of derivatives depends on the intended use of the derivative and its resultant designation. The Company had no significant derivative or hedging instruments during the years ended December 31, 2021, 2020 or 2019.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

**O.Pension and Other Postretirement Benefits**

The obligations for the Company's pension plans and postretirement benefit plans and the related annual costs of employee benefits are calculated based on several long-term assumptions, including discount rates for employee benefit liabilities, rates of return on plan assets, expected annual rates of salary increases for employee participants in the case of pension plans and expected annual increases in the costs of medical and other health care benefits in the case of postretirement benefit plans. These long-term assumptions are subject to revision based on changes in interest rates, financial market conditions, expected versus actual returns on plan assets, participant mortality rates and other actuarial assumptions, including future rates of salary increases, benefit formulas and levels, and rates of increase in the costs of benefits. Changes in these assumptions, if significant, can materially affect the amount of annual net periodic benefit costs recognized in the Company's results of operations from one year to the next, the liabilities for the pension plans and postretirement benefit plans and the Company's annual cash requirements to fund these plans. See Note 12. *Pension and Other Postretirement Benefits* for further information regarding our pension and postretirement plans.

**P.Income Taxes**

We and US Holding have entered into a Tax Allocation Agreement ("Tax Allocation Agreement"), dated as of November 16, 2020, with members of an affiliated group, as defined in Section 1504(a) of the U.S. Internal Revenue Code of 1986, as amended (the "Tax Code"), members of one or more consolidated, combined, unitary or similar state tax groups and additional parties who are part of an "expanded affiliated group" for certain tax purposes. The agreement provides for the method of computing and allocating the consolidated U.S. federal tax liability of the affiliated group among its members and of allocating any state group tax liabilities among the state members for the taxable year ending December 31, 2021 and each subsequent year in which the parties are members of a group (whether federal or state). The agreement also provides for reimbursement of US Holding and/or DRS for payment of such tax liabilities, for compensation of any member for use of its "net operating loss" or "tax credits" in arriving at such tax liabilities and the allocation and payment of any refund arising from a carryback of net operating losses or tax credits from subsequent taxable years. Under the agreement, the parties have agreed to calculate and allocate their respective tax liabilities and other tax attributes for taxable years beginning with the first consolidated taxable year that included DRS (i.e., the taxable year ended December 31, 2008) as if the agreement was then in effect.

The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Income taxes as presented attribute deferred income taxes of US Holding to DRS in a manner that is systematic, rational and consistent with the asset and liability method and the governing Tax Allocation Agreement which allocates the tax liability amongst the entities, including DRS.

The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax basis of DRS' assets and liabilities and are adjusted for changes in tax rates and tax laws when such changes are enacted.

In general, the taxable income of DRS is included in the consolidated U.S. federal and state tax returns of US Holding. Where applicable, US Holding's current portion of U.S. federal income taxes payable were offset against DRS' net operating loss carryforwards in the period the related tax expense was recorded. Consequently, our net operating loss carryforwards are deemed to have been settled with US Holding in each year in an amount commensurate with the carrying value of the tax effected net operating loss utilized.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

If management determines that some portion or all of a deferred tax asset is not "more likely than not" to be realized, a valuation allowance is recorded as a component of the income tax provision to reduce the deferred tax asset to the amounts expected to be realized. In determining whether the Company's deferred tax assets are realizable, management considers all evidence, both positive and negative, including the history of financial reporting earnings, existing taxable temporary differences and their projected reversals, as well as projected future income and tax planning strategies. We believe it is more likely than not that we will generate sufficient taxable income in future periods to realize our deferred tax assets, subject to the valuation allowances recognized.

The Company assesses its tax positions for all periods open to examination by tax authorities based on the latest available information. Those positions are evaluated to determine whether they will more likely than not be sustained upon examination by the relevant taxing authorities. Liabilities for unrecognized tax benefits are measured based on the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. These unrecognized tax benefits are recorded as a component of income tax expense. Interest and penalties related to unrecognized tax benefits are not material.

See *Note 10*: *Income Taxes* for additional information regarding income taxes.

**Q.Earnings Per Share**

Basic earnings per share ("EPS") is computed by dividing net earnings by the weighted average number of shares of common stock outstanding during each period. The computation of diluted EPS includes the dilutive effect of outstanding stock-based compensation awards, only in periods in which such effect would have been dilutive for the period. In February 2021, the Company completed a forward stock split of 1-for-1,450,000 shares of common stock. Additionally, on November 23, 2022, the Company completed a forward stock split of 1-for- 1.451345331 shares of common stock. The consolidated financial statements have been retroactively adjusted as necessary to reflect the November 23, 2022 forward stock split for all periods presented. There were 145 million and 210.45 million basic and diluted common shares outstanding before and after the November 23, 2022 forward stock split, respectively, for all periods presented.

**R.Fair Value Measurements**

Fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant on the measurement date. We are required to maximize the use of observable inputs and minimize the use of unobservable inputs in measuring fair value, and to utilize a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The three hierarchical levels used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs other than quoted prices that are directly or indirectly observable.

Level 3 — Significant inputs to the valuation model are unobservable.

In certain instances, fair value is determined through information obtained from third parties using the latest available market data. In obtaining such data from third parties, we have evaluated the methodologies used to develop the estimate of fair value in order to assess whether such valuations are representative of fair value. The Company categorizes plan assets for disclosure purposes in accordance with this fair value hierarchy. Certain plan investments are measured at fair value using the net asset value ("NAV") per share (or its equivalent) practical expedient and are therefore not categorized as Level 1, 2, or 3. NAV is defined as the total value of the fund divided by the number of the fund's shares

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

outstanding. See *[Note 12: Pension and Other Postretirement Benefits](#i195ed586c79140398faaf3bea4dcb04b_115)* for further information regarding our pension and postretirement plans.

**S.Financial Instruments**

Our financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and other current liabilities. Financial instruments are reported in the Consolidated Balance Sheet at carrying value, which other than the 7.5% Term loan due November 30, 2023, approximate fair value. See *[Note 11: Debt](#i195ed586c79140398faaf3bea4dcb04b_112)* for further information regarding our debt.

**T.Acquisitions, Investments, Variable Interest Entities and Divestitures**

*Acquisitions*

Our consolidated financial statements include the operations of acquired businesses from the date of acquisition. We account for acquired businesses using the acquisition method of accounting, which requires that any assets acquired and liabilities assumed be measured at their respective fair values on the acquisition date. The accounting for business combinations requires the Company to make significant judgments and estimates. Any excess of the fair value of consideration transferred over the assigned values of the net assets acquired is recognized as goodwill.

During the third quarter of 2021 the Company acquired substantially all the assets of Ascendant Engineering Solutions (AES), an advanced gimbal producer located in Austin, TX. The purchase closed on July 28, 2021 for a purchase price of $11 million with an additional $5 million payable upon the achievement of certain financial and operational targets.

AES designs, develops and manufactures high-performance, stabilized, multi-sensor gimbal systems for the growing market of Group 1, 2 and 3 unmanned aerial systems (UAS) serving several branches of the DoD. The company is focused on gimbal payload opportunities in strategic U.S. government programs including those intended to counter current and next-generation anti-access and area-denial systems. We believe this acquisition enables the integration of our own Electro-Optical and Infrared systems with the gimbals of AES and is a strategic investment, offering an integrated solution for our customers in the market for lightweight military platforms including small unmanned aerial systems. The acquisition has been accounted for as a business combination and has been integrated into our Advanced Sensing and Computing segment.

*Investments*

Investments where we have the ability to exercise significant influence, but do not control, are accounted for under the equity method of accounting and are included in other noncurrent assets on our Consolidated Balance Sheet. Significant influence typically exists if we have a 20% to 50% ownership interest in the investee. Under this method of accounting, our share of the net earnings or losses of the investee is included in operating profit in other income, net on our Consolidated Statements of Earnings (Loss) since the activities of the investee are closely aligned with the operations of the business segment holding the investment. We evaluate our equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, a loss is therefore recorded during the current period. See *Note 13: Equity Method Investments* for further information regarding our equity method investments.

The Company's cost method investment consists of an investment in a private company in which we do not have the ability to exercise significant influence over its operating and financial activities. Management evaluates this investment for possible impairment quarterly.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

*Variable Interest Entities*

The Company occasionally forms joint ventures and/or enters into arrangements with special purpose limited liability companies for the purpose of bidding and executing on specific projects. The Company analyzes each such arrangement to determine whether it represents a variable interest entity ("VIE"). If the arrangement is determined to be a VIE, the Company assesses whether it is the primary beneficiary of the VIE and if it is, consequently required to consolidate the VIE. The Company did not have any investment in VIEs as of December 31, 2021 or 2020.

**U.New Accounting Pronouncements**

***Recently Adopted Accounting Pronouncements***

*Changes to Disclosure Requirements for Defined Benefit Plans*

In August 2018, the FASB issued ASU 2018-14, *Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans*. Specifically, the amendment removes disclosure requirements for amounts classified in accumulated other comprehensive income expected to be recognized over the next year and the effects of a one-percentage-point change in the assumed health care cost trend rate on service cost, interest cost and the benefit obligation for postretirement benefits. The amendment also requires additional disclosure around weighted-average interest crediting rates for cash balance plans, a narrative description of the reasons for significant gains and losses, and an explanation of any other significant changes in the benefit obligation or plan assets. The adoption of the standard as of January 1, 2021 did not have a material impact on our consolidated financial statements.

*Simplifying the Accounting for Income Taxes*

In December 2019, the FASB issued ASU 2019-12, *Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes* which removes certain exceptions to the general principles in Topic 740 for: recognizing deferred taxes for investments, performing intra-period allocations and calculating taxes in interim periods. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The standard is effective for fiscal years beginning after December 15, 2020. The adoption of the standard as of January 1, 2021 did not have a material impact on our consolidated financial statements.

***Accounting Guidance Issued but Not Yet Adopted as of December 31, 2021:***

*Government Assistance*

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): *Disclosure by Business Entities about Government Assistance* which requires certain disclosures to be included with respect to the types of assistance, the accounting for the assistance as well as the effect on the financial statements of the assistance. The purposes of the ASU is to increase transparency and eliminate disparity of accounting for and reporting of the receipt of government assistance. The standard is effective for fiscal periods beginning after December 15, 2021. The Company does not expect the adoption to have a material impact on our disclosures.

**Note 2. Revenue from Contracts with Customers**

The Company recognizes revenue for each separately identifiable performance obligation in a contract representing an obligation to transfer a distinct good or service to a customer. In most cases, goods and services provided under the Company's contracts are accounted for as single performance obligations due to the complex and integrated nature of our products and services. These contracts generally require significant integration of a group of goods and/or services to deliver a combined output.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

In some contracts, the Company provides multiple distinct goods or services to a customer. In those cases, the Company accounts for the distinct contract deliverables as separate performance obligations and allocates the transaction price to each performance obligation based on its relative standalone selling price, which is generally estimated using cost plus a reasonable margin. We classify revenues as products or services on our Consolidated Statements of Earnings based on the predominant attributes of the performance obligations. While the Company provides warranties on certain contracts, we typically do not provide for services beyond standard assurances and therefore do not consider warranties to be separate performance obligations. Typically we enter into three types of contracts: fixed-price contracts, cost-plus contracts and T&M contracts (cost-plus contracts and T&M contracts are aggregated below as flexibly priced contracts). The majority of our total revenues are derived from fixed-price contracts; refer to the revenue disaggregation disclosures that follow.

For fixed-price contracts, customers agree to pay a fixed amount, negotiated in advanced for a specified scope of work.

For cost-plus contracts typically we are reimbursed for allowable or otherwise defined total costs (defined as cost of revenues plus allowable general and administrative expenses) incurred, plus a fee. The contracts may also include incentives for various performance criteria, including quality, timeliness and cost-effectiveness. In addition, costs are generally subject to review by clients and regulatory audit agencies, and such reviews could result in costs being disputed as non-reimbursable under the terms of the contract.

T&M contracts provide for reimbursement of labor hours expended at a contractual fixed labor rate per hour, plus the actual costs of material and other direct non-labor costs. The fixed labor rates on T&M contracts include amounts for the cost of direct labor, indirect contract costs and profit.

Estimating the transaction price for an arrangement requires judgment and is based on expected results which are determined using the Company's historical data. We estimate that the revenue that we expect to be entitled to receive from a customer to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur.

Revenue from contracts with customers is recognized when the performance obligations are satisfied through the transfer of control over the good or service to the customer, which may occur either over time or at a point in time.

Revenues for the majority of our contracts are measured as determined by the ratio of cumulative costs incurred to date to estimated total contract costs at completion (the "cost-to-cost method"). We believe this is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of our work and transfer of control to our customers. Due to the long-term nature of many of our contracts, developing the estimated total cost at completion and total transaction price often requires judgment. Factors that must be considered in estimating the cost of the work to be completed include the nature and complexity of the work to be performed, subcontractor performance and the risk and impact of delayed performance.

After establishing the estimated total cost at completion, we follow a standard Estimate at Completion ("EAC") process in which we review the progress and performance on our ongoing contracts at least quarterly. Adjustments to original estimates for a contract's revenue, estimated costs at completion and estimated profit or loss often are required as work progresses under a contract, as experience is gained and as more information is obtained, even though the scope of work required under the contract may not change and are also required if contract modifications occur. When adjustments in estimated total costs at completion or in estimated total transaction price are determined, the related impact on revenue and operating income are recognized using the cumulative catch-up method, which recognizes in the current period the cumulative effect of such adjustments for all prior periods. Any anticipated losses on these contracts are fully recognized in the period in which the losses become evident.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

EAC adjustments had the following impacts to revenue for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Revenue | $(34) | $(77) | $(55) |
| Total % of Revenue | 1% | 3% | 2% |

---

The impacts noted above are attributed primarily to changes in our firm-fixed-price development type programs. As changes happen in the design required to achieve contractual specifications, those changes often result in the programs' estimate and related profitability. The reductions to revenue for the years ended December 31, 2021, 2020 and 2019 were related to certain masted surveillance and submarine electric propulsion programs within our IMS segment, solider sensing programs within our ASC segment and adjustments to the measurement of variable consideration related to certain requests for equitable adjustment with the U.S. Navy also within our ASC segment.

Conversely, if the requirements for the recognition of contracts over time are not met, revenue is recognized at a point in time when control transfers to the customer, which is generally upon transfer of title. In such cases, the production that is in progress and costs that will be recognized at a future point in time are reported within "inventories".

Costs to obtain a contract are incremental direct costs incurred to obtain a contract with a customer, including sales commissions and dealer fees, and are capitalized if material. Costs to fulfill a contract include costs directly related to a contract or specific anticipated contract (e.g., certain design costs) that generate or enhance our ability to satisfy our performance obligations under these contracts. These costs are capitalized to the extent they are expected to be recovered from the associated contract.

*Contract Assets and Liabilities* 

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals (e.g., biweekly or monthly) or upon achievement of contractual milestones. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, we sometimes receive advances or deposits from our customers before revenue is recognized, resulting in contract liabilities.

---

| | | |
|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Contract assets | $743 | $672 |
| Contract liabilities | 174 | 177 |
| **Net contract assets**  | $569 | $495 |

---

Revenue recognized in 2021 and 2020 that was included in the contract liability balance at the beginning of each year was $108 million and $104 million, respectively.

The change in the balances of the Company's contract assets and liabilities primarily results from timing differences between revenue recognition and customer billings and/or payments.

Contract assets related to amounts withheld by customers until contract completion are not considered a significant financing component of our contracts because the intent is to protect the customers from our failure to satisfactorily complete our performance obligations. Payments received from customers in advance of revenue recognition (contract liabilities) are not considered a significant financing component of our contracts because they are utilized to pay for contract costs within a one-year period or are requested by us to ensure the customers meet their payment obligations.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

*Value of Remaining Performance Obligations*

The value of remaining performance obligations, which we also refer to as total backlog, includes the following components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Funded - Funded backlog represents the revenue value of orders for services under existing contracts for which funding is appropriated or otherwise authorized less revenue previously recognized on these contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Unfunded - Unfunded backlog represents the revenue value of firm orders for products and services under existing contracts for which funding has not yet been appropriated less funding previously recognized on these contracts.

The following table summarizes the value of our backlog at December 31, 2021 and 2020:

---

| | | |
|:---|:---|:---|
| **Backlog:** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Funded | $2510 | $2847 |
| Unfunded | 351 | 444 |
| **Total Backlog**  | $2861 | $3291 |

---

We expect to recognize approximately 62.5% of our December 31, 2021 backlog as revenue over the next 12 months, with the remainder to be recognized thereafter.

*Disaggregation of Revenue*

*ASC*: ASC revenue is primarily derived from U.S. government development and production contracts and is generally recognized over time using the cost-to-cost method. We disaggregate ASC revenue by geographical region, customer relationship and contract type. We believe these categories best depict how the nature, amount, timing and uncertainty of ASC revenue and cash flows are affected by economic factors:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| **Revenue by Geographical Region** |  |  |  |
| United States | $1808 | $1763 | $1699 |
| International | 113 | 182 | 99 |
| Intersegment Sales | 19 | 13 | 12 |
| **Total**  | $1940 | $1958 | $1810 |
| **Revenue by Customer Relationship** |  |  |  |
| Prime contractor | $1209 | $1063 | $1027 |
| Subcontractor | 712 | 882 | 771 |
| Intersegment Sales | 19 | 13 | 12 |
| **Total**  | $1940 | $1958 | $1810 |
| **Revenue by Contract Type** |  |  |  |
| Firm Fixed Price | $1667 | $1716 | $1570 |
| Flexibly Priced<sup>(1)</sup> | 254 | 229 | 228 |
| Intersegment Sales | 19 | 13 | 12 |
| **Total**  | $1940 | $1958 | $1810 |

---

________________

(1)Includes revenue derived from time-and-materials contracts.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

*IMS*: IMS revenue is primarily derived from U.S. government development and production contracts and is generally recognized over time using the cost-to-cost method. We disaggregate IMS revenue by geographical region, customer relationship and contract type. We believe these categories best depict how the nature, amount, timing and uncertainty of IMS revenue and cash flows are affected by economic factors:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| **Revenue by Geographical Region** |  |  |  |
| United States | $913 | $792 | $895 |
| International | 45 | 41 | 21 |
| Intersegment Sales | 1 | 1 | 1 |
| **Total**  | $959 | $834 | $917 |
| **Revenue by Customer Relationship** |  |  |  |
| Prime contractor | $174 | $283 | $442 |
| Subcontractor | 784 | 550 | 474 |
| Intersegment Sales | 1 | 1 | 1 |
| **Total**  | $959 | $834 | $917 |
| **Revenue by Contract Type** |  |  |  |
| Firm Fixed Price | $831 | $692 | $763 |
| Flexibly Priced<sup>(1)</sup> | 127 | 141 | 153 |
| Intersegment Sales | 1 | 1 | 1 |
| **Total**  | $959 | $834 | $917 |

---

________________

(1)Includes revenue derived from time-and-materials contracts.

**Note 3. Accounts Receivable**

Accounts receivable represent amounts billed and currently due from customers. Payment is typically received from our customers either at periodic intervals (e.g., biweekly, or monthly) or upon achievement of contractual milestones.

Accounts receivable consist of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Accounts receivable | $157 | $104 |
| Less allowance for doubtful accounts | (1) | (2) |
| **Accounts receivable, net**  | $156 | $102 |

---

The Company maintains certain agreements with financial institutions to sell certain trade receivables. Receivables are derecognized in their entirety when sold, and the Company's continuing involvement in the sold receivables is limited to their servicing, for which the Company receives a fee commensurate with the service provided. Pursuant to the servicing agreements, the Company collected approximately $15 million and $27 million at December 31, 2021 and 2020, respectively, of these sold receivables that had not yet been remitted to the financial institutions. These unremitted amounts collected on behalf of the financial institutions are included within short-term borrowings and current portion of long-term debt in the Consolidated Balance Sheet.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

**Note 4. Inventories**

Inventories consists of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Raw materials | $43 | $52 |
| Work in progress | 161 | 193 |
| Finished goods | 1 | 2 |
| **Total**  | $205 | $247 |

---

**Note 5. Property, Plant and Equipment**

Property, plant and equipment by major asset class consists of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Land, buildings and improvements | $312 | $294 |
| Plant and machinery | 191 | 186 |
| Equipment and other | 298 | 276 |
| Total property, plant and equipment, at cost | 801 | 756 |
| Less accumulated depreciation | (437) | (401) |
| **Total property, plant and equipment, net**  | $364 | $355 |

---

Depreciation expense related to property, plant and equipment was $49 million, $44 million and $42 million for the years ended December 31, 2021, 2020 and 2019, respectively.

Land, buildings and improvements include assets under finance leases in the amount of $104 million and $108 million as of December 31, 2021 and 2020, respectively. See *[Note 9: Leases](#i195ed586c79140398faaf3bea4dcb04b_106)* for additional information.

As of December 31, 2021, the Company accounted for our manufacturing facility in Menomonee Falls, WI as a build-to-suit lease with a failed sale-leaseback and is included in the Land, building, and improvements in the above table. See *Note 11: Debt* for additional information.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

**Note 6. Other Liabilities**

A summary of significant other liabilities by balance sheet caption follows:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Salaries, wages and accrued bonuses | $70 | $61 |
| Fringe benefits | 74 | 71 |
| Litigation | 10 | 10 |
| Restructuring costs | 4 | 1 |
| Provision for contract losses | 48 | 44 |
| Operating lease liabilities | 24 | 22 |
| Other<sup>(1)</sup> | 65 | 58 |
| **Total other current liabilities**  | $295 | $267 |
| Retirement benefits | $— | $— |
| Operating lease liabilities | $73 | $81 |
| Other<sup>(2)</sup> | 1 | 11 |
| **Total other noncurrent liabilities**  | $74 | $92 |

---

________________

(1)Consists primarily of taxes payable, environmental remediation reserves and warranty reserves. *See Note 15: Commitments and Contingencies* for more information regarding the warranty provision.

(2)Consists primarily of workers' compensation liabilities and certain payroll taxes deferred under the CARES Act.

**Note 7. Goodwill**

Changes in the carrying amount of goodwill by reportable segment are as follows:

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **ASC** | **IMS** | **Total** |
| **Balance at January 1, 2020** <sup>(1)</sup>  | $638 | $419 | $1057 |
| Acquisitions |  |  |  |
| **Balance at December 31, 2020**  | 638 | 419 | 1057 |
| Acquisitions | 14 |  | 14 |
| **Balance at December 31, 2021**  | $652 | $419 | $1071 |

---

________________

(1)Goodwill is reported net of $2,362 million, and $606 million of accumulated impairments as of January 2020 for the ASC and IMS segments, respectively.

**Note 8. Intangible Assets**

Other intangible assets mainly refer to the fair value of existing customer contractual relationships attributable to the acquired business and patents which are being amortized over their respective lives. The fair value of intangible assets typically is determined, as of the date of acquisition, based on estimates and judgments regarding expectations for the estimated future after-tax earnings and cash flows (including cash flows for working capital) arising from backlog and follow-on sales to the customer over their estimated lives, including the probability of expected future contract renewals and sales, less a contributory assets charge, all of which is discounted to present value.

The following disclosure presents certain information regarding the Company's intangible assets as of December 31, 2021 and 2020. All intangible assets are being amortized over their estimated useful lives, as indicated below, with no estimated residual values.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2020** | **December 31, 2020** | **December 31, 2020** |
| *(Dollars in millions)* | **Gross<br> Carrying <br>Amount** | **Accumulated Amortization** | **Net Carrying Amount** | **Gross <br>Carrying<br> Amount** | **Accumulated Amortization** | **Net Carrying Amount** |
| Customer relationships | $957 | $(908) | $49 | $957 | $(899) | $58 |
| Patents and licenses | 9 | (6) | 3 | 7 | (5) | 2 |
| **Total intangible assets**  | $**966** | $**(914)** | $**52** | $964 | $(904) | $60 |

---

Amortization expense related to intangible assets was $9 million, $9 million, and $9 million respectively, for the years ended December 31, 2021, 2020 and 2019.

Customer relationships are amortized on a straight-line basis over their estimated useful lives of 10 to 15 years. Patents and licenses are amortized on a straight-line basis over their estimated useful lives of 5 to 10 years. The estimated annual amortization expense related to intangible assets for the subsequent five years is as follows:

---

| | |
|:---|:---|
| *(in millions)*<br>Year Ending December 31, | **Estimated Annual Amortization** |
| 2022 | $9 |
| 2023 | 9 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 9 |

---

&nbsp;&nbsp;&nbsp;&nbsp;**Note 9. Leases**

The Company leases various real estate for manufacturing facilities, administrative offices and warehouses under both finance leases and operating leases. In addition, the Company leases vehicles, machinery and office equipment under operating leases. We determine whether our contracts are or contain a lease at the inception of such arrangements. A contract is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

ROU assets and lease liabilities are recorded on the Consolidated Balance Sheet as of the lease commencement based on the present value of the future lease payments over the lease term. As our leases do not generally explicitly state the discount rate implicit in the lease, we use our incremental borrowing rate, which is determined based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term as of the lease commencement date. In addition to the present value of the future lease payments, the calculation of the ROU asset also includes lease payments made at or before the commencement date of the lease, less any lease incentives received. The remaining lease cost is amortized over the remaining life of the lease on a straight-line basis. We evaluate ROU assets for impairment consistent with the treatment of other long-lived assets.

Some of our leases include options to extend the lease terms or to terminate the lease early. We include the impact of the option in the determination of the ROU assets and liabilities when it is reasonably certain that we will exercise the option. Our lease payments are largely fixed, but may include variable payments that do not depend on an index or rate, such as usage-based amounts, and are recorded as a lease expense in the period incurred. The Company's lease agreements do not contain any material residual value guarantees or restrictive covenants.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

In 2019, we have entered into a sale-leaseback transaction related to a facility in Milwaukee, WI. We have analyzed the transaction and determined the criteria to recognize a sale has been met and we have derecognized the related assets. The arrangement does not contain a repurchase option or other substantive obligations related to the property. Further, we have determined that the underlying lease meets the criteria to be classified as an operating lease. As a result, we have recognized an immaterial loss related to the transaction.

As of December 31, 2021, the Company has not entered into any significant leases that have not yet commenced. We elected not to recognize a ROU asset and lease liability for leases with an initial term of 12 months or less. These leases are expensed on a straight-line basis over the lease term. The Company elected the practical expedient to not separate lease and non-lease components and to instead account for them as a single component. We have elected this practical expedient for all classes of assets.

***Lease Cost***

The Company's total lease cost consists of the following:

---

| | | |
|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Operating lease cost<sup>(1)</sup> | $26 | $24 |
| Finance lease cost<sup>(2)</sup>: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | 8 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on lease liabilities | 5 | 5 |
| **Total lease cost**  | $39 | $36 |

---

________________

(1)Operating lease expense is included within cost of products, cost of services or general and administrative expenses, dependent upon the nature and use of the ROU asset, in the Company's Consolidated Statements of Earnings Operating lease cost includes short-term leases of approximately $3 million and $5 million and an insignificant amount of variable lease cost for both 2021 and 2020.

(2)Finance lease expense is recorded as depreciation and amortization expense within cost of products, cost of services or general and administrative expenses, dependent upon the nature and use of the ROU asset and interest expense, net in the Company's Consolidated Statements of Earnings.

***Supplemental Balance Sheet Information***

Supplemental balance sheet information related to leases is as follows:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| **ROU assets** |  |  |
| Operating leases<sup>(1)</sup> | $84 | $88 |
| Finance leases<sup>(2)</sup> | 104 | 108 |
| **Total leased assets**  | $188 | $196 |
| **Liabilities** |  |  |
| Current lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating<sup>(1)</sup> | $24 | $22 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance<sup>(2)</sup> | 6 | 5 |
| Noncurrent lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating<sup>(1)</sup> | 73 | 81 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance<sup>(2)</sup> | 107 | 109 |
| **Total lease liabilities**  | $210 | $217 |

---

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

________________

(1)Operating lease assets are included within other noncurrent assets and operating lease liabilities are included within other current liabilities (current portion) and other noncurrent liabilities (noncurrent portion) in the Company's Consolidated Balance Sheet.

(2)Finance lease assets are included within property, plant and equipment, net and finance lease liabilities are included within short-term borrowings and current portion of long-term debt (current portion) and long-term debt (noncurrent portion) in the Company's Consolidated Balance Sheet.

***Supplemental Cash Flow Information***

Supplemental cash flow information related to leases is as follows:

---

| | | |
|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from operating leases | $27 | $27 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from finance leases | 5 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing cash flows from finance leases | 5 | 4 |
| Right-of-use assets obtained in exchange for new lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 18 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 4 | 46 |

---

***Weighted Average Lease Term and Discount Rate***

Lease terms and discount rates related to leases are as follows:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2021** | **2020** |
| Weighted-average remaining lease term: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 5 years | 5 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 15 years | 16 years |
| Weighted-average discount rate: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 4.3% | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 4.6% | 4.5% |

---

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

***Maturity of Lease Liabilities:***

As of December 31, 2021, future minimum rental payments on leases with initial non-cancellable lease terms in excess of one year were due as follows:

---

| | | |
|:---|:---|:---|
| *(Dollars in millions)* | **Operating Leases** | **Finance Leases** |
| **Year Ending December 31,** |  |  |
| 2022 | $27 | $11 |
| 2023 | 25 | 11 |
| 2024 | 19 | 11 |
| 2025 | 12 | 10 |
| 2026 | 9 | 10 |
| Thereafter | 14 | 104 |
| **Total lease payments**  | 106 | 157 |
| Less: imputed interest | 9 | 44 |
| **Present value of lease liabilities**  | 97 | 113 |
| Less: current maturities | 24 | 6 |
| **Long-term lease obligations**  | $73 | $107 |

---

**Note 10. Income Taxes**

Earnings (loss) before taxes consists of the following:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Earnings before taxes |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Domestic | $203 | $112 | $89 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign | (3) |  | 6 |
| **Total**  | $200 | $112 | $95 |

---

Income tax provision (benefit) consists of the following:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| Current: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal | $(1) | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;State |  | 3 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign | 1 | 2 | 1 |
|  |  | 5 | 3 |
| Deferred: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal | 43 | 24 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;State | 5 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign | (2) | (2) |  |
|  | 46 | 22 | 17 |
| **Total**  | $46 | $27 | $20 |

---

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The reconciliation from the statutory federal income tax rate to our effective income tax rate follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| | **2021** | **2020** | **2019** |
| Statutory federal rate | 21.0% | 21.0% | 21.0% |
| State rate, net of federal benefit | 3.6% | 2.3% | 0.5% |
| Foreign rate differential | (0.2)% | 0.5% | 0.5% |
| Research & development credit, net of reserves | (0.2)% | (0.7)% | (2.3)% |
| Nondeductible expenses | 0.9% | 0.4% | 0.7% |
| Global intangible low taxed income | —% | 0.2% | 1.0% |
| Change in valuation allowance | (1.4)% | (2.5)% | 0.2% |
| Change in tax reserves | (0.4)% | 2.2% | 0.2% |
| Other | (0.3)% | 0.7% | (0.7)% |
| Effective tax rate | 23.0% | 24.1% | 21.1% |

---

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2021 and 2020 is as follows:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| *(Dollars in millions)* | **2021** | **2020** |
| Deferred tax assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal net operating losses | $5 | $18 |
| &nbsp;&nbsp;&nbsp;&nbsp;State net operating losses | 16 | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax credit carryforwards | 21 | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and benefits | 23 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | 21 | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 5 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and post-retirement plans | 18 | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory capitalization | 5 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 5 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Disallowed interest | 1 | 1 |
| **Total gross deferred tax assets**  | 120 | 154 |
| Less valuation allowance | 10 | 11 |
| Deferred tax assets | 110 | 143 |
| Deferred tax liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets | (41) | (44) |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed assets | (12) | (11) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (1) | (1) |
| **Deferred tax liabilities**  | (54) | (56) |
| **Net deferred tax asset**  | $56 | $87 |

---

Our deferred tax balance associated with our retirement benefit plans includes a deferred tax asset of $11 million and $14 million as of December 31, 2021 and 2020 respectively, that are recorded in accumulated other comprehensive earnings to recognize the funded status of our retirement plans. See*'Note 12: Pension and Other Postretirement Benefits* for additional details. As of December 31, 2021 and 2020 the Company had U.S. federal net operating loss carryforwards of $28 million and $131 million, respectively, which we anticipate we will be able to apply prior to their expiration which commences in 2025. The annual utilization of approximately $28 million of certain our Federal net operating losses is subject to limitations under section 382 of the Internal Revenue Code. As of December 31, 2021 and

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

2020 we had apportioned state net operating loss carryforwards of $239 million and $327 million, respectively, which are associated with jurisdictions in which we currently file and the Company expects to utilize prior to expiration except for those for which we have recorded a valuation allowance. We have federal tax credit carryforwards that commence expiring in 2032, which we anticipate being able to utilize prior to their expiration.

***Tax Uncertainties***

The Company maintains reserves for uncertain tax positions related to unrecognized income tax benefits. These reserves involve considerable judgment and estimation and are evaluated by management at least quarterly based on the best information available. The Company's total liability for unrecognized tax benefits as of December 31, 2021, 2020 and 2019 was approximately $22 million, $25 million and $18 million, respectively; all of which will impact the effective tax rate when recognized. Approximately $15 million, $22 million and $16 million as of December 31, 2021, 2020 and 2019, respectively, have been recorded within (and as an offset to) deferred tax assets. In addition, the Company does not believe there are any tax positions for which it is reasonably possible that the unrecognized tax benefits will vary significantly over the next 12 months. The table below summarizes the activity associated with our unrecognized tax benefits:

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| **Balance at January 1,**  | $25 | $18 | $14 |
| Increase related to prior year tax positions |  | 3 | 3 |
| Increase related to current year tax positions | 1 | 4 | 1 |
| Decreases related to prior year tax positions | (4) |  |  |
| Lapse of statute of limitations |  |  |  |
| Settlements with taxing authorities |  |  |  |
| **Balance at December 31,**  | $22 | $25 | $18 |

---

The Company is subject to U.S. federal income tax as well as income tax of multiple state and foreign jurisdictions. The Company has substantially concluded all U.S. federal income tax matters for years through the tax year ended December 31, 2016 except as it relates to the net operating loss carryforward and tax credit carryforwards. Substantially all material state and local matters have been concluded for years through the tax year ended December 31, 2015. The Company has substantially concluded all material tax matters in foreign jurisdictions for years through the tax years ending during 2016.

As of December 31, 2021, the Company has accumulated undistributed earnings generated by our foreign subsidiaries and most have been taxed in the U.S. as a result of the Tax Cuts and Jobs Act of 2017 (the "TCJA"). The TCJA allows for a dividend received deduction for repatriation of foreign earnings. We intend to indefinitely reinvest these earnings. Should the Company's undistributed earnings from its investment in non-U.S. subsidiaries be distributed in the future in the form of dividends or otherwise, the Company may be subject to foreign and domestic income taxes and withholding taxes.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

&nbsp;&nbsp;&nbsp;&nbsp;**Note 11. Debt** 

The Company's debt consists of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
|<br>*(Dollars in millions)* | **2021** | **2020** |
| 7.5% Term loan due November 30, 2023<sup>(1)</sup> | 139 | 139 |
| 5.0% Daylight term loan due October 15, 2024<sup>(1)</sup> | 78 | 98 |
| Finance lease and other | 161 | 163 |
| Short-term borrowings | 15 | 27 |
| **Total debt principal**  | 393 | 427 |
| Less unamortized debt issuance costs and discounts |  |  |
| **Total debt, net**  | 393 | 427 |
| Less short-term borrowings and current portion of long-term debt | (41) | (53) |
| **Total long-term debt**  | $352 | 374 |

---

________________

(1)The Company's debt with related parties consists of two term loans and a working capital credit facility with US Holding, as described below.

***Term Loans***

In January 2009, the Company entered into a credit agreement with its ultimate parent company, Finmeccanica S.p.A. (presently Leonardo S.p.A.) in the amount of $2 billion (the "2009 Credit Agreement"). The 2009 Credit Agreement was subsequently assigned to US Holding and has a maturity of November 30, 2023. The 2009 Credit Agreement provides for a term loan bearing interest at a rate of 7.5%, with interest payments due semi-annually on June 20 and December 20 in each year (the "7.5% Term loan"). The outstanding balance of the 7.5% Term loan at December 31, 2021 and 2020 was $139 million and $139 million, respectively. The fair value of this term loan at December 31, 2021 and 2020 was $182 million and $182 million, respectively; however the Company has the ability to prepay the outstanding principal balance at the carrying amount without penalty. During 2020, US Holding forgave $300 million of related party debt. This was treated as a capital transaction and the amount was recorded in additional paid-in capital, as US Holding is a related party.

In June 2017, the Company entered into an unsecured term loan with US Holding in the principal amount of $137.5 million, the proceeds of which were used to finance the acquisition of Daylight Solutions, Inc. (the "Daylight Term Loan"). The Daylight Term Loan had an outstanding balance of $78 million and $98 million at December 31, 2021 and 2020, respectively, which approximates its fair value. The Daylight Term Loan matures on October 15, 2024. The Daylight Term Loan has an interest rate of 5.0%, with interest payments due semi-annually on April 15 and October 15.

During April 2018, the Company was advanced an additional $50 million by US Holding under a term loan. This term loan bears interest at 4.0% and had an initial maturity date of December 31, 2018, which was extended until December 31, 2021. This term loan was repaid in full, with no prepayment penalty, on December 19, 2020.

***Credit Facilities***

The 2009 Credit Agreement provides for a revolving credit facility available for working capital needs of the Company (the "Revolving Credit Facility"). As of December 31, 2021 and 2020, the Revolving Credit Facility had a credit limit of $450 million and $450 million, respectively, and an interest rate of LIBOR plus 3.5%. There is a commitment fee of 0.25% applied to the unused balance of the Revolving Credit Facility and there are no compensating balance requirements. There was no balance on the Revolving Credit Facility as of December 31, 2021 and 2020.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The Company also maintains uncommitted working capital credit facilities with certain financial institutions in the aggregate of $65 million and $60 million at December 31, 2021 and 2020, respectively (the "Financial Institution Credit Facilities"). The Financial Institution Credit Facilities are guaranteed by Leonardo S.p.A. The primary purpose of the Financial Institution Credit Facilities is to support standby letter of credit issuances on contracts with customers and also includes a revolving facility with a maximum borrowing limit of $15 million, which bears interest at LIBOR plus 0.5%. At December 31, 2021 and 2020, there was no balance outstanding on the revolving facility. The Company had letters of credit outstanding of approximately $35 million and $31 million as of December 31, 2021 and 2020, respectively, which reduces the available capacity of the Financial Institution Credit Facilities by an equal amount.

***Finance Lease and Other***

As of December 31, 2021, finance lease and other of $161 million includes approximately $113 million related to finance lease liabilities and $48 million related to our Menomonee Falls, WI manufacturing facility, which has been accounted for as a build-to-suit lease with a failed sale leaseback. Approximately $6 million has been recognized as the current portion of long-term debt for the finance lease liabilities and financing liability related to the build-to-suit arrangement.

***Short-term Borrowings***

As of December 31, 2021 and 2020, the Company recognized $15 million and $27 million, respectively, collected on behalf of the buyers of our trade receivables pursuant to our factoring arrangements as short-term borrowings and current portion of long-term debt in the Consolidated Balance Sheet, which approximates its fair value. Refer to *Note 3: Accounts Receivable* for more information.

***Interest Paid***

Total interest paid associated with our debt was $35 million, $64 million and $65 million in 2021, 2020 and 2019, respectively.

***Maturities of long-term debt as of December 31, 2021 are as follows:***

---

| | |
|:---|:---|
| *(Dollars in millions)* |  |
| **Year Ending December 31,** |  |
| 2022 | $41 |
| 2023 | 171 |
| 2024 | 40 |
| 2025 | 7 |
| 2026 | 7 |
| Thereafter | 127 |
| **Total principal payments**  | $393 |

---

**'Note 12. Pension and Other Postretirement Benefits**

***Retirement Plan Summary Information***

The Company maintains multiple pension plans, both contributory and non-contributory, covering employees at certain locations. Eligibility requirements for participation in the plans vary, and benefits generally are based on the participant's compensation and years of service, as defined in the respective plan. The Company's funding policy generally is to contribute in accordance with cost accounting standards that affect government contractors, subject to the Tax Code and regulations thereunder. Plan assets are invested primarily in equities, bonds (both corporate and U.S. government), U.S. government-sponsored entity instruments, cash and cash equivalents and real estate.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The Company also provides postretirement medical benefits for certain retired employees and dependents at certain locations. Participants are eligible for these benefits when they retire from active service and meet the eligibility requirements for the Company's postretirement benefit plans. The Company's contractual arrangements with the U.S. government provide for the recovery of contributions to a Voluntary Employees' Beneficiary Association ("VEBA") trust and, for non-funded plans, recovery of claims on a pay-as-you-go basis, subject to the Tax Code and regulations thereunder, with the retiree generally paying a portion of the costs through contributions, deductibles and coinsurance provisions.

The Company also maintains certain non-contributory and unfunded supplemental retirement plans. Eligibility for participation in the supplemental retirement plans is limited, and benefits generally are based on the participant's compensation and/or years of service.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The following tables provide certain information regarding the Company's pension, postretirement and supplemental retirement plans as of December 31, 2021 and 2020:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| *(Dollars in millions)* | **2021** | **2020** | **2021** | **2020** | **2021** | **2020** |
| **Change in benefit obligation:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefit obligation at beginning of year | $226 | $261 | $2 | $3 | $23 | $24 |
| &nbsp;&nbsp;&nbsp;&nbsp;Service cost |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest cost | 5 | 7 |  |  | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plan participants' contributions |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Actuarial (gain) loss | (3) | (10) |  | (1) | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefits paid | (13) | (10) |  |  | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss due to settlement |  | (21) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Plan amendments |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exchange rate differences and other |  | (1) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefit obligation at end of year | $215 | $226 | $2 | $2 | $22 | $23 |
| **Change in plan assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of plan assets at beginning of year | $151 | $158 | $1 | $1 | $11 | $10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Actual return on plan assets | 15 | 19 |  |  | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plan participants' contributions |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employer contributions | 13 | 6 |  |  | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefits paid | (13) | (10) |  |  | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Loss) gain due to settlement |  | (21) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exchange rate differences and other |  | (1) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of plan assets at end of year | 166 | 151 | 1 | 1 | 12 | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contributions between measurement date and year end |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Funded status of the plans at year end | $(49) | $(75) | $(1) | $(1) | $(10) | $(12) |

---

The amounts recognized in the Consolidated Balance Sheet, as of December 31, 2021 and 2020 consist of:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| *(Dollars in millions)* | **2021** | **2020** | **2021** | **2020** | **2021** | **2020** |
| Noncurrent assets | $— | $— | $1 | $1 | $— | $— |
| Current liabilities |  |  |  |  |  |  |
| Noncurrent liabilities | (49) | (75) | (2) | (2) | (10) | (11) |
| **Net liability recognized**  | $(49) | $(75) | $(1) | $(1) | $(10) | $(11) |

---

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

Amounts recognized in accumulated other comprehensive income (before taxes) at December 31, 2021 and 2020 consist of:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| *(Dollars in millions)* | **2021** | **2020** | **2021** | **2020** | **2021** | **2020** |
| Prior service cost | $— | $— | $— | $— | $— | $— |
| Net actuarial loss (gain) | 40 | 52 | (1) | (2) | 6 | 7 |
| &nbsp;&nbsp;&nbsp;**Total amount recognized in accumulated other comprehensive losses (earnings)**  | $40 | $52 | $(1) | $(2) | $6 | $7 |

---

The aggregate accumulated benefit obligation ("ABO") for the Company's defined benefit pension plans combined was $237 million and $249 million at December 31, 2021 and 2020, respectively. The ABO represents benefits accrued without assuming future compensation increases to plan participants and is approximately equal to our projected benefit obligation ("PBO").The table below presents information for the pension plans with an ABO and PBO in excess of the fair value of plan assets at December 31, 2021 and 2020.

---

| | | |
|:---|:---|:---|
| *(Dollars in millions)* | **December 31, 2021** | **December 31, 2020** |
| Projected benefit obligation | $237 | $249 |
| Accumulated benefit obligation | 237 | 249 |
| Fair value of plan assets | 178 | 162 |

---

The following table summarizes the weighted average actuarial assumptions used to determine our benefit obligations at December 31, 2021 and 2020:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| | **2021** | **2020** | **2021** | **2020** | **2021** | **2020** |
| **Rate assumptions** |  |  |  |  |  |  |
| Discount rate | 2.8% | 2.4% | 2.6% | 4.3% | 2.8% | 2.5% |
| Increase in future compensation levels | N/A | N/A | N/A | N/A | N/A | N/A |
| Expected long-term return on plan assets | 5.9% | 6.4% | 5.9% | 6.4% | N/A | N/A |
| Health care trend rate assumed for next year | N/A | N/A | 4.6% | 5.4% | N/A | N/A |
| Ultimate health care trend rate | N/A | N/A | 4.3% | 4.3% | N/A | N/A |
| Year rate reaches ultimate trend rate | N/A | N/A | 2031 | 2031 | N/A | N/A |

---

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The following table summarizes the components of net periodic benefit cost for the Company's pension, postretirement and supplemental retirement plans for the years ended December 31, 2021 and 2020 and 2019:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** | **2021** | **2020** | **2019** | **2021** | **2020** | **2019** |
| Service cost | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| Interest cost | $5 | $7 | $7 | $— | $— | $— | $1 | $1 | $1 |
| Expected return on plan assets | $(7) | $(8) | $(7) | $— | $— | $— | $— | $— | $— |
| Amortization of net actuarial loss (gain) | $2 | $3 | $2 | $(1) | $(1) | $— | $— | $— | $— |
| Amortization of prior service cost | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| Settlement expense (income) | $— | $3 | $— | $— | $— | $— |  | $— | $— |
| **Net periodic benefit cost**  | $— | $5 | $2 | $(1) | $(1) | $— | $1 | $1 | $1 |

---

The following table summarizes the other changes in plan assets and benefit obligations recognized in other comprehensive earnings for the Company's pension, postretirement and supplemental retirement benefit plans for the years ended December 31, 2021 and 2020 and 2019:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** | **2021** | **2020** | **2019** | **2021** | **2020** | **2019** |
| Net actuarial (gain) loss | $(11) | $(21) | $19 | $— | $(1) | $(1) | $(1) | $(1) | $4 |
| Prior service cost |  |  |  |  |  |  |  |  |  |
| Amortization of net actuarial (loss) gain from prior years | (2) | (6) | (2) | 1 | 1 |  |  |  |  |
| Amortization of prior service cost |  |  |  |  |  |  |  |  |  |
| Other<sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| **Total recognized in other comprehensive income**  | $(13) | $(27) | $17 | $1 | $— | $(1) | $(1) | $(1) | $4 |

---

________________

(1) Includes foreign exchange translation.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The following table summarizes the weighted average actuarial assumptions used to determine our net periodic cost of the plans for the years ended December 31, 2021, 2020 and 2019:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** | **Supplemental Retirement Plans** |
| | **2021** | **2020** | **2019** | **2021** | **2020** | **2019** | **2021** | **2020** | **2019** |
| **Rate assumptions** |  |  |  |  |  |  |  |  |  |
| Discount rate | 2.8% | 2.7% | 3.6% | 2.1% | 2.8% | 3.3% | 2.4% | 2.4% | 3.5% |
| Expected long - term return on plan assets | 6.4% | 6.3% | 6.9% | 6.4% | 5.8% | 5.7% | N/A | N/A | N/A |
| Increase in future compensation levels | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Health care trend rate assumed for next year | N/A | N/A | N/A | 5.8% | 6.0% | 6.5% | N/A | N/A | N/A |
| Ultimate health care trend rate | N/A | N/A | N/A | 4.5% | 4.5% | 4.5% | N/A | N/A | N/A |
| Year rate reaches ultimate trend rate | N/A | N/A | N/A | 2030 | 2029 | 2027 | N/A | N/A | N/A |

---

The expected long-term return on plan assets assumption represents the average rate that the Company expects to earn over the long-term on the assets of the Company's benefit plans, including those from dividends, interest income and capital appreciation. The assumption has been determined based on expectations regarding future rates of return for the plans' investment portfolio, with consideration given to the allocation of investments by asset class and historical rates of return for each individual asset class.

A one percentage increase or decrease in healthcare trend rates in the table above would have an insignificant impact to our service and interest cost and the postretirement medical obligations.

**Plan Assets**

The Company is responsible for formulating the investment policies and strategies for each plan's assets. Presently all of the plans are governed by a single investment policy and are uniformly invested. As part of the policy statement the Company has implemented a glide path which adjusts the percentage of assets invested in return seeking assets based upon the attainment of specific funding percentages. The non-return seeking assets are invested primarily in bonds with maturities closely matching the anticipated payment of benefits.

The table below represents all of the Company's funded pension plans' and postretirement benefit plans' weighted-average asset allocation at December 31, 2021 and 2020 by asset category:

---

| | | |
|:---|:---|:---|
| | **Asset Allocation** | **Asset Allocation** |
| | **2021** | **2020** |
| **Asset Category** |  |  |
| Equity securities | 41% | 55% |
| Debt securities | 47% | 33% |
| Real estate | 6% | 6% |
| Other, primarily cash and cash equivalents, and hedge funds | 6% | 6% |

---

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The table below presents the target allocation ranges for each major asset category for the Company's benefit plans for the years ended December 31, 2021 and 2020.

---

| | | |
|:---|:---|:---|
| | **Target Asset Allocation Range** | **Target Asset Allocation Range** |
| | **2021** | **2020** |
| **Asset Category** |  |  |
| Equity securities | 40% - 60% | 40% - 60% |
| Debt securities | 30% - 50% | 40% - 50% |
| Real estate | 5% - 10% | 5% - 10% |
| Other, primarily cash and cash equivalents and hedge funds | 5% - 10% | 5% - 10% |

---

The following tables provides the fair value of plan assets held by our defined benefit plan by asset category and by fair value hierarchy level. Certain investments are measured at their NAV per share and do not have readily determined fair values. As such, these investments are not subject to leveling in the fair value hierarchy.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| *(Dollars in millions)* | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Asset category** |  |  |  |  |
| *Investments measured at fair value:* | $— | $— | $— | $— |
| Cash and cash equivalents | $11 | $— | $— | $11 |
| Equity securities | 6 |  |  | 6 |
| Debt securities |  |  |  |  |
| Total | $17 | $— | $— | $17 |
| *Investments measured at NAV:* |  |  |  |  |
| Collective trust funds |  |  |  | 162 |
| Equity and fixed income funds |  |  |  |  |
| Total  | $17 | $— | $— | $179 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2020** | **December 31, 2020** | **December 31, 2020** | **December 31, 2020** |
| *(Dollars in millions)* | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Asset category** |  |  |  |  |
| *Investments measured at fair value:* |  |  |  |  |
| Cash and cash equivalents | $9 | $— | $— | $9 |
| Equity securities | 6 |  |  | 6 |
| Debt securities |  |  |  |  |
| Total | $15 | $— | $— | $15 |
| *Investments measured at NAV:* |  |  |  |  |
| Collective trust funds |  |  |  | 148 |
| Equity and fixed income funds |  |  |  |  |
| **Total**  | $15 | $— | $— | $163 |

---

For the year ended December 31, 2022, the Company expects to contribute $5 million to its pension plans and an inconsequential amount to its postretirement plans. During 2020 the Company deferred approximately $7 million in pension contributions until 2021 under the CARES Act and IRS Notice 2020-82, which was included in the total pension contributions for 2021 of $13 million.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

The following table presents expected pension and postretirement benefit payments over the next 10 years:

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **Defined Benefit Pension Plans** | **Postretirement Benefit Plans** | **Supplemental Retirement Plans** |
| Year Ending December 31, |  |  |  |
| 2022 | $12 | $— | $1 |
| 2023 | 12 |  | 1 |
| 2024 | 13 |  | 1 |
| 2025 | 13 |  | 1 |
| 2026 | 13 |  | 1 |
| 2027-2031 | 63 |  | 6 |

---

**Defined Contribution Plans**

The Company maintains defined contribution plans covering substantially all domestic full-time eligible employees. The Company's contributions to these plans for the years ended December 31, 2021, 2020 and 2019 amounted to $22 million, $21 million and $19 million, respectively.

**Note 13. Equity Method Investments**

Our share of net earnings related to our equity method investments was $2 million, $3 million and $2 million for the years ended December 31, 2021, 2020 and 2019, respectively, which was included in our Advanced Sensing and Computing business segment operating profit.

Below is a list of the entities accounted for under the equity method and recorded in other noncurrent assets on our Consolidated Balance Sheet:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **% of Ownership** | **% of Ownership** | **Carrying Value** | **Carrying Value** |
| *(Dollars in millions)* | **2021** | **2020** | **2021** | **2020** |
| Advanced Acoustics Concepts, LLC | 51% | 51% | $27 | $25 |

---

**Note 14. Share-based compensation plans**

The Company does not have any share-based compensation plans. See *Note 6*: *Other Liabilities*, for information regarding cash compensation.

**Note 15. Commitments and Contingencies**

***Commitments***

The Company's commitments are primarily related to our lease and credit agreements. See *Note 9*: *Leases* and *Note 11*: *Debt* for additional information on our leases and credit agreements.

***Contingencies***

From time to time we are subject to certain legal proceedings and claims in the ordinary course of business. These matters are subject to many uncertainties and it is possible that some of these matters ultimately could be decided, resolved or settled in a manner adverse to us. Although the precise amount of liability that may result from these matters is not ascertainable, the Company believes that any amounts exceeding the Company's recorded accruals should not materially adversely affect the Company's financial condition or liquidity. It is possible, however, that the ultimate resolution of those matters could result in a material adverse effect on the Company's results of operations and/or cash flows from operating activities for a particular reporting period. We establish reserves for specific legal matters

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

when we determine that the likelihood of an unfavorable outcome is probable and the loss is reasonably estimable.

Some environmental laws, such as the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (also known as "CERCLA" or the "Superfund law") and similar state statutes, can impose liability upon former owners or operators for the entire cost of investigating and remediating contaminated sites regardless of the lawfulness of the original activities that led to the contamination. In July 2000, an entity which later became a subsidiary of the Company received a Section 104(e) Request for Information ("RFI") from the National Park Service ("NPS"), pursuant to CERCLA, regarding the presence of radioactive material at a site within a national park, which site was operated by an alleged predecessor to our subsidiary over 50 years ago. Following the subsidiary's response to the RFI, the NPS directed it and another alleged former operator to perform an Engineering Evaluation and Cost Analysis ("EE/CA") of a portion of the site. The Company's subsidiary made a good faith offer to conduct an alternative EE/CA work plan, but the NPS rejected this offer and opted to perform the EE/CA itself. The NPS previously posted its intention to open a formal public comment period regarding the EE/CA at the end of 2019. To the Company's knowledge, the EE/CA has not been released and a public comment period has yet to be opened.

Following completion of the EE/CA, the NPS may seek reimbursement for its investigative and remedial efforts to date, or direct one or more of the potentially responsible parties to perform any remediation that may be required by CERCLA or may enter an alternative dispute resolution proceeding to attempt to resolve each party's share. In addition, the NPS may seek to recover damages for loss of use of certain natural resources. The Company believes that it has legitimate defenses to its subsidiary's potential liability and that there are other potentially responsible parties for the environmental conditions at the site, including the U.S. government as owner, operator and arranger at the site. The potential liability associated with this matter could change substantially due to such factors as additional information on the nature or extent of contamination, methods of remediation that might be recommended or required, changes in the apportionment of costs among the responsible parties, whether the NPS seeks to recover additional damages, whether the NPS's plans to investigate additional areas to identify a need for further remedial action for which the Company may be identified as a potentially responsible party and other actions by governmental agencies or private parties.

The Company has recorded its best estimate of damages and its share of remediation costs related to the site to reflect what we and our advisors reasonably believe we would be liable for based on the current information and circumstances of the claim, exclusive of other potential liabilities that may be asserted in the future.

In the performance of our contracts we routinely request contract modifications that require additional funding from the customer. Most often, these requests are due to customer-directed changes in the scope of work. While we are entitled to recovery of these costs under our contracts, the administrative process with our customer may be protracted. Based on the circumstances, we periodically file requests for equitable adjustment ("REAs") that are sometimes converted into claims. In some cases, these requests are disputed by our customer. We believe our outstanding modifications, REAs and other claims will be resolved without material impact to our results of operations, financial condition or cash flows.

As a government contractor, with customers including the U.S. government as well as various state and local government entities, the Company may be subject to audits, investigations and claims with respect to its contract performance, pricing, costs, cost allocations and procurement practices. Additionally, amounts billed under such contracts, including direct and indirect costs, are subject to potential adjustments before final settlement.

Management believes that adequate provisions for such potential audits, investigations, claims and contract adjustments, if any, have been made in the Consolidated Financial Statements.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

***Restructuring costs***

We engage in targeted restructuring initiatives in order to rationalize headcount and align our operations in a more strategic and cost-efficient structure. In connection with these restructuring initiatives we recorded charges totaling $5 million, $12 million and $20 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs incurred were related to employee termination and severance costs, as well as costs related to discontinuing product lines or closing down of locations. Charges were recorded within other operating expenses, net, with the exception of costs incurred related to the write-down of inventory, which were recorded in cost of products. See the table below for a breakout of restructuring costs incurred by segment and by nature of cost incurred:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| **ASC**  |  |  |  |
| Severance | $5 | $6 | $1 |
| Facility abandonment |  |  | 3 |
| Inventory |  |  | 2 |
| **Total ASC**  | 5 | 6 | 6 |
| **IMS**  |  |  |  |
| Severance |  |  | 2 |
| Facility abandonment |  | 6 | 6 |
| Inventory |  |  | 5 |
| **Total IMS**  |  | 6 | 13 |
| **Corporate**  |  |  |  |
| Severance |  |  |  |
| Facility abandonment |  |  | 1 |
| Inventory |  |  |  |
| **Total Corporate**  |  |  | 1 |
| **Total**  | $5 | $12 | $20 |

---

The following is a summary of changes in the restructuring provision balance during the years ended December 31, 2020 and 2021:

---

| | |
|:---|:---|
| *(Dollars in millions)* |  |
| **Balance at January 1, 2020**  | $4 |
| Additional provision | 12 |
| Reversal and utilization | (15) |
| **Balance at December 31, 2020**  | 1 |
| Additional provision | 5 |
| Reversal and utilization | (2) |
| **Balance at December 31, 2021**  | $4 |

---

***Product Warranties***

Product warranty costs generally are accrued in proportion to product revenue realized in conjunction with our over-time revenue recognition policy. Product warranty expense is recognized based on the term of the product warranty, generally one year to three years, and the related estimated costs, considering historical claims expense. Accrued warranty costs are reduced as these costs are incurred and as the warranty period expires, and otherwise may be modified as specific product performance issues are

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

identified and resolved. The following is a summary of changes in the product warranty balances during the years ended December 31, 2020 and 2021:

---

| | |
|:---|:---|
| *(Dollars in millions)* |  |
| **Balance at January 1, 2020**  | $13 |
| Additional provision | 16 |
| Reversal and utilization | (12) |
| **Balance at December 31, 2020**  | 17 |
| Additional provision | 17 |
| Reversal and utilization | (15) |
| **Balance at December 31, 2021**  | $19 |

---

**Note 16. Related Party Transactions**

Under our current proxy agreement, DRS remains largely independent from the Parent. Additionally, the Company provides services related to the US interface for the Parent and its other affiliates. These services include financial, tax, trade compliance, marketing and communications and legal.

The Company also has related-party sales with the Parent and its other affiliates that occur in the regular course of business. Related-party sales for these transactions are included in revenues and were $11 million, $26 million and $16 million for the years ended December 31, 2021, 2020 and 2019, respectively. The receivables related to these transactions with the Parent and its other affiliates of $2 million and $5 million, respectively, and payables of $1 million and $8 million, respectively, are included in accounts receivable and accounts payable in our Consolidated Balance Sheet as of December 31, 2021 and 2020.

The Company entered into a Surplus Treasury Agreement with US Holding (the "Surplus Agreement") in December 2019. The Surplus Agreement allows the Company to advance excess funds to US Holding when funds are available. The advances bear interest at LIBOR plus between 5 and 20 basis points depending on the tenor of the advance. As of December 31, 2021 and 2020, the Company had advanced $0 million and $115 million to US Holding, which is presented on the balance sheet as a related party note receivable.

During 2020, US Holding forgave $300 million of related party debt. This was treated as a capital transaction and the amount was recorded in additional paid-in capital, as US Holding is a related party.

The Company entered into Tax Allocation Agreement with US Holding, dated as of November 16, 2020. Refer to *Note 1: Summary of Significant Accounting Policies* for more information.

**Note 17. Segment Information**

Operating segments represent components of an enterprise for which separate financial information is available that is regularly reviewed by the CODM in determining how to allocate resources and assess performance. Our Chief Executive Officer is our CODM and he uses a variety of measures to assess the performance of the Company as a whole, depending on the nature of the activity. The Company's operating and reportable segments consist of ASC and IMS. All other operations, which consists primarily of DRS Corporate Headquarters and certain non-operating subsidiaries of the Company, are grouped in Corporate & Eliminations.

We primarily use Adjusted EBITDA to manage the Company and allocate resources. Adjusted EBITDA of our business segments includes our net earnings before income taxes, amortization of acquired intangible assets, depreciation, restructuring costs, interest, deal related transaction costs , acquisition and divestiture related expenses, foreign exchange, COVID-19 response costs, non-service pension expenditures and other one-time non-operational events. Adjusted EBITDA is used to facilitate a comparison of the ordinary, ongoing and customary course of our operations on a consistent basis from

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

period to period and provide an additional understanding of factors and trends affecting our business segments. This measure assists the CODM in assessing segment operating performance consistently over time without the impact of our capital structure, asset base and items outside the control of the management team and expenses that do not relate to our core operations.

Certain information related to our segments for the years ended December 31, 2021, 2020 and 2019, is presented in the following tables. Consistent accounting policies have been applied by all segments within the Company, within all reporting periods. A description of our reportable segments as of December 31, 2021 and 2020 has been included in *Note 1: Summary of Significant Accounting Policies*. Transactions between segments generally are negotiated and accounted for under terms and conditions that are similar to other government and commercial contracts; however, these intercompany transactions are eliminated in consolidation.

Total revenues and intersegment revenues by segment for the years ended December 31, 2021, 2020 and 2019 consists of the following:

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| ASC | $1940 | $1958 | $1810 |
| IMS | 959 | 834 | 917 |
| Corporate & Eliminations | (20) | (14) | (13) |
| **Total revenue**  | $2879 | $2778 | $2714 |

---

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| ASC | $19 | $13 | $12 |
| IMS | 1 | 1 | 1 |
| **Total intersegment revenue**  | $20 | $14 | $13 |

---

Depreciation by segment as of December 31, 2021, 2020 and 2019 consists of the following:

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| ASC | $33 | $30 | $29 |
| IMS | 16 | 14 | 13 |
| **Total depreciation**  | $49 | $44 | $42 |

---

Total assets by segment as of December 31, 2021 and 2020 consist of the following:

---

| | | |
|:---|:---|:---|
| *(Dollars in millions)* | **2021** | **2020**<sup>(1)</sup> |
| ASC | $1545 | $1563 |
| IMS | 1145 | 1018 |
| Corporate & Eliminations | 379 | 375 |
| **Total assets**  | $3069 | $2956 |

---

<sup>(1)</sup> The 2020 amounts have been adjusted to reflect the correction of the allocation of certain assets within each segment.

------

**LEONARDO DRS, INC.&nbsp;&nbsp;&nbsp;&nbsp;**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)** 

Reconciliation of reportable segment Adjusted EBITDA to Net Earnings (loss) consists of the following:

---

| | | | |
|:---|:---|:---|:---|
| *(Dollars in millions)* | **2021** | **2020** | **2019** |
| **Adjusted EBITDA**  |  |  |  |
| ASC | $220 | $213 | $169 |
| IMS | 90 | 55 | 63 |
| Corporate & Eliminations |  |  | 2 |
| **Total Adjusted EBITDA**  | $310 | $268 | $234 |
| Amortization of intangibles | (9) | (9) | (9) |
| Depreciation | (49) | (44) | (42) |
| Restructuring costs | (5) | (12) | (20) |
| Interest expense | (35) | (64) | (65) |
| Deal related transaction costs | (5) | (9) |  |
| Acquisition and divestiture related expenses |  |  |  |
| Foreign exchange | (1) | (1) |  |
| COVID-19 response costs | (6) | (12) |  |
| Non-service pension expense |  | (5) | (3) |
| Other one-time non-operational events |  |  |  |
| Income tax provision | (46) | (27) | (20) |
| **Net earnings**  | $154 | $85 | $75 |

---

**Note 18. Subsequent Events**

The Company has evaluated subsequent events through March 27, 2023, which represents the date on which the Consolidated Financial Statements were issued.

On March 21, 2022, the Company entered into a definitive agreement to sell its Global Enterprise Solutions (GES) business to SES Government Solutions, Inc., a wholly-owned subsidiary of SES S.A., for $450 million in cash. GES, which was part of the ASC segment for all periods reported, provides commercial satellite communications to the U.S. Government and delivers satellite communications and security solutions to customers worldwide. SES S.A. has guaranteed the payment of the purchase price and performance of all other obligations of SES Government Solutions, Inc. under the agreement. The transaction was completed on August 1, 2022.

In February 2022, the Leonardo DRS Board of Directors approved the strategic initiative to divest of the Company's interest in AAC. On April 19, 2022, we entered into a definitive sales agreement to divest our share of our current equity investment in Advanced Acoustic Concepts (AAC) to Thales Defense & Security, Inc (TDSI), the minority partner in the Joint Venture. The sale was completed on July 8, 2022.

On June 21, 2022, the Company entered into a definitive agreement with RADA Electronic Industries Ltd., a leading provider of advanced software-defined military tactical radars, to merge and become a combined public company. On November 28, 2022 the merger completed and RADA became a wholly-owned subsidiary of Leonardo DRS.

------